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NOTATIONS
B Symptom Symptôme
D Disease Maladie
B(D) Set of symptom typical of disease D Ensemble des symptômes typiques de D
Bi Set of symptoms typical of at least one Ensemble des symptômes typiques d’au
disease in common with diseases moins une maladie commune avec les
for which Bi is typical maladies dont Bi est typique
H Entropy Entropie
KL Kullback-Leibler divergence Divergence de Kullback-Leibler
pi Diagnostic strategy Stratégie de diagnostic
µ Behaviour policy Stratégies générant les données
S State space Espace des états
A Action space Espace des actions
st State visited at time t Etat visité au temps t
at Action taken at time t Action prise à l’instant t
rt Instantaneous reward received at time t Récompenses instantanée reçu au temps t
Vpi(s) Value function Fonction de valeur
Qpi(s, a) State-action value Valeur action-état
s(i) State with presence of symptom Bi Etat avec présence du symptôme Bi
and no other information et aucune autre information
St Random variable of which st Variable aléatoire dont st
is a realization est une réalisation
I Number of inquiries before Nombre de question à poser avant
reaching a terminal state d’atteindre un état terminal
P Law of the environment Loi de l’environnement

Chapter 1
INTRODUCTION EN LANGUE
FRANCAISE
Résumé: Afin de planter le décor, nous commencons par un bref tour
d’horizon du monde du diagnostic prénatal en évoquant les enjeux, les
acteurs et les techniques mobilisées. Nous évoquons ensuite les données
à disposition et les informations que nous avons pu tirer des différentes
bases existantes en libre accès pour les maladies rares. Nous continuons
en explicitant le besoin actuel des échographistes pour un outil d’aide
à la décision précisant par la même occasion les propriétés désirables
que doit posséder notre algorithme final. Nous finissons en essayant de
prendre de la hauteur et de formuler les questions mathématiques plus
générales qui sont abordées dans cette thèse.
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Les travaux présentés dans cette thèse sont le résultat de mes trois ans de recherche sous
la direction de mes deux directeurs de thèse, Erwan Le Pennec et Stéphanie Allassonnière,
sur un sujet à l’interface mathématiques/médecine.
L’objectif de ce projet est de fournir aux praticiens du diagnostic prénatal un outil
d’aide à la décision lors de la recherche de maladie rare par échographie.
Mon travail durant ces trois années s’est inscrit au sein d’une équipe pluridisci-
plinaire regroupant des mathématiciens, Erwan, Stéphanie et moi-même, des médecins
obstétriciens, Julien Stirnemann, Emmanuel Spaggiari et Yves Ville, ainsi qu’un médecin
spécialiste de santé publique, Antoine Neuraz.
1.1 Le dépistage et le diagnostic prénatal
1.1.1 Enjeux du diagnostic prénatal
La France enregistre chaque année environ 780.000 naissances dont 39.000 pour la seule
région parisienne et on estime que 3 à 4 pour cent de ces grossesses sont affectées d’au
moins une anomalie congénitale (voir Khoshnood B [2016]).
Les anomalies congénitales sont une cause importante de mortalité infantile: 21 %
des décès dans la première année de la vie sont imputables à de telles anomalies d’après
l’Institut de veille sanitaire 1. Elles représentent également une partie conséquente des
handicaps.
Il est donc clair que l’ensemble des malformations congénitales représente un enjeu
de santé publique. Cependant si l’existence d’une anomalie congénitale est un évènement
relativement fréquent, le grand nombre de pathologies différentes possibles dont un grand
nombre sont des maladies rares, rend la tâche de l’obstétricien difficile.
1.1.2 Les outils mobilisables pour le diagnostic prénatal
L’échographie, parce qu’elle constitue une technique non-invasive et peu coûteuse, reste
l’outil privilégié du dépistage prénatal. En France, la femme enceinte est tenue de suivre
trois examens échographiques de contrôle à 12, 21, puis 33 semaines d’aménorrhée (absence
1. http://invs.santepubliquefrance.fr//Dossiers-thematiques/Maladies-chroniques-et-traumatismes/
Malformations-congenitales-et-anomalies-chromosomiques. Accessed [04/03/2019]
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de règles). Si une anomalie est détectée ou suspectée, la patiente est orientée vers un
médecin spécialiste pour une échographie de seconde intention, dite aussi "échographie de
diagnostic".
Si un risque significatif d’anomalie chromosomique (par exemple une trisomie 21) est
identifié, une amniocentèse doit être proposée à la mère. L’amniocentèse consiste à prélever
du liquide amniotique par ponction abdominale. L’étude du caryotype des cellules fœtales
doit permettre de diagnostiquer avec certitude l’anomalie chromosomique suspectée. Elle
est effectuée vers la 17e semaine d’aménorrhée. Cette technique intrusive a longtemps été
considérée comme comportant des risques pour le foetus, le chiffre de 1% d’augmentation
de risque de fausse couche attribué à l’amniocentèse a longtemps été avancé. Cependant,
une étude récente de médecins de Necker a montré, lors d’essais randomisés sur 2051
femmes, qu’en utilisant les techniques actuelles il n’existe pas d’augmentation statistique-
ment significative du risque de fausse couche Malan et al. [2018]. Il n’en reste pas moins
que cet examen est plus coûteux et complexe qu’une échographie et n’est donc pas utilisé
en routine pour du dépistage.
De plus, insistons ici sur le fait que l’amniocentèse permet de détecter uniquement les
syndromes dont les anomalies du caryotype sont bien connus ce qui est loin d’être le cas
de toutes les maladies rares. Ces considérations expliquent le choix des syndromes retenus
pour notre base de données (voir section 1.2): il doit s’agir de syndrome pour lequel il
n’existe pas déjà un moyen fiable et sans risque de les identifier.
Enfin citons l’existence des examens d’imagerie par résonance magnétique (IRM) et
de tomodensitométrie (TDM). Ces examens sont réalisés à la suite d’une échographie de
diagnostic lorsque celle-ci a mis en évidence une anomalie. Ils doivent permettre "d’étudier
certains organes ou certaines structures du foetus ou de ses annexes de façon différente
et complémentaire à l’échographie. Les régions anatomiques les plus souvent explorées en
IRM sont le système nerveux central, le thorax et l’abdomen du fœtus. La TDM explore
le squelette fœtal." 2
Notons donc la place particulièrement importante de l’échographie dans le dépistage
prénatal puisqu’utilisée systématiquement en routine. Celle-ci constitue également la
meilleure solution pour diagnostiquer un certains nombres de malformations. En effet,
comme le rappelle l’arrêté du 20 Avril 2018 sur les bonnes pratiques dans le diagnostic
prénatal: "l’échographie obstétricale et fœtale est dans certains cas le seul examen perme-
ttant d’identifier un risque pour le fœtus ou la grossesse en cours, de diagnostiquer une
pathologie fœtale ou obstétricale et de la surveiller".
2. Extrait de l’annexe 1 de l’arrêté du 20 avril 2018 fixant les recommandations de bonnes pratiques
relatives aux modalités de réalisation des examens d’imagerie concourant au diagnostic prénatal.
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1.1.3 Les acteurs
Comme précisé dans l’article 1 du décret du 2 mai 2017 (2017-702) seuls les "sages-femmes
et médecins disposant de compétences reconnues par un diplôme en attestant" sont habil-
ités à réaliser les échographies obstétricales et foetales. Les prérogatives de ces deux corps
de métiers ne sont cependant pas identiques.
Les sages-femmes sont titulaires d’un diplôme d’Etat les habilitant à mener les échogra-
phies de dépistage (de contrôle). Les échographies dites de diagnostic ne font, à l’inverse,
pas partie de leur champ de compétences. Leur profession est encadrée par les articles
L4151 du code de la santé publique.
Les médecins habilités à suivre la grossesse d’une femme sont les obstétriciens.
Lorsqu’une anomalie congénitale grave est suspectée, les patients sont orientés vers les
Centres Pluridisciplinaires de Diagnostic Prénatal (CPDPN), qui étaient au nombre de
49 sur le territoire français en 2015. Le diagnostic final précisant la nature et le niveau
de gravité de la malformation est posé de manière collégiale par au moins deux médecins
spécialistes de diagnostic prénatal.
1.1.4 Les solutions thérapeutiques possibles
Lorsqu’une malformation congénitale est diagnostiquée, la question de la prise en charge
est alors évoquée. La prise de décision est toujours faite de manière collégiale par des
médecins de différentes spécialités et en lien avec les Centres Pluridisciplinaires de Diag-
nostic Prénatal. La décision finale revenant toujours, bien sûr, aux parents.
Si l’affection de l’enfant à naître est identifiée comme étant d’une particulière grav-
ité, c’est-à-dire impliquant un handicap lourd sans solution thérapeutique existante, une
interruption médicale de grossesse (IMG) est envisageable et ce jusqu’au dernier jour de
grossesse. Il s’agit de l’Article L2213-1 du Code de la santé publique:
L’interruption volontaire d’une grossesse peut, à toute époque, être pratiquée
si deux médecins membres d’une équipe pluridisciplinaire attestent, après que
cette équipe a rendu son avis consultatif, soit que la poursuite de la grossesse
met en péril grave la santé de la femme, soit qu’il existe une forte probabil-
ité que l’enfant à naître soit atteint d’une affection d’une particulière gravité
reconnue comme incurable au moment du diagnostic.
Notons qu’il n’est pas rare que l’IMG soit refusée par les parents alors que le prognostic
vital néonatal est très pessimiste Guibet Lafaye [2009]. Dans de tels cas le diagnostic préna-
tal aura permis d’envisager en amont les soins palliatifs éventuels à fournir au nouveau-né
dès sa naissance Charlot [2011].
Il convient ici d’embellir quelque peu ce sombre tableau et de souligner les progrès
récents de la chirurgie foetale source d’espoir pour l’avenir. Ainsi le prognostic vital des
foetus atteint du syndrome de transfuseur-transfusé pour des grossesses multiples a été
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grandement amélioré avec les avancées récentes de la chirurgie in foeto. Sans intervention
la mortalité périnatale est de 90 % et des séquelles neurologiques graves sont retrouvées
chez 20 à 40 % des survivants. Les techniques récentes permettent la survie d’un des deux
jumeaux dans près de 80% des cas et un risque de séquelle chez les survivants de moins
de 10 % Salomon and Ville [2008]. Citons également les opérations in foeto possible pour
les malformations de type spina-bifida: une anomalie de fermeture du tube neural dont la
prévalence est d’une naissance sur 2000. Il a été prouvé que cette opération améliore de
manière notable le prognostic du handicap de l’enfant à naître par rapport à la solution
alternative d’opérer en néonatal (voir Adzick et al. [2011]). De manière générale, c’est
seulement lorsqu’une telle démonstration a été faite que la chirurgie foetale est considérée
comme une alternative pleinement justifiée puisque, bien sûr, celle-ci n’est pas sans risque
pour la mère et l’enfant qu’elle porte. Cette technique est cependant suffisemment sûre
aujourd’hui pour être proposée même dans le cas de malformations non létales (A Deprest
et al. [2010]).
1.1.5 Les questions de responsabilités pénales
Nous ne prétendons pas, bien sûr, donner un aperçu exhaustif des questions de respon-
sabilité pénale que fait émerger le diagnostic prénatal. Le lecteur imaginera sans peine
combien ces questions peuvent être complexes et sans cesse en évolution.
En France, deux organismes d’Etat distincts ont été créés pour régler les contentieux
entre patient et soignants afin d’offrir une alternative rapide et gratuite face à la voie judi-
ciaire. Il s’agit de la commission de conciliation et d’indemnisation des accidents médicaux
(CCI) et de l’Office National d’Indemnisation des Accidents Médicaux (ONIAM). La CCI a
pour fonction de fournir une expertise pour l’établissement d’une responsabilité éventuelle
du soignant ou de l’établissement de santé. L’ONIAM a plus spécifiquement pour mission
d’organiser le dispositif d’indemnisation.
Si une responsabilité est établie par la CCI, l’assureur du professionnel de santé doit
faire une proposition d’indemnisation qui sera acceptée ou refusée par la victime, en cas
de refus celle-ci devra se tourner vers les tribunaux compétents.
Le nombre de réclamations envoyées à la CCI est en constante augmentation depuis les
années 2000 (voir figure 1.1). La gynécologie obstétrique fait partie des spécialités pour
lesquelles les coûts d’indemnisation judiciaire sont les plus élevés. La Mutuelle d’assurances
du corps de santé français (MACSF) publie chaque année son rapport sur les procédures
d’indemnisation et, en 2017, la gynécologie obstétrique arrive en troisième place avec
presque 6 millions d’euros d’indemnisation (voir figure 1.2).
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Figure 1.1 – Evolution du nombre d’entrées dans le dispositif de la commission de concili-
ation et d’indemnisation des accidents médicaux (source: Office National d’Indemnisation
des Accidents Médicaux rapport annuel de 2017).
Figure 1.2 – Les décisions aux tribunaux civils concernant les litiges en médecine pour
l’année 2017 selon les différentes spécialités (source: MACSF - Le Sou Médical, rapport
annuel).
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1.2 Les données à disposition
1.2.1 Une première base experte
Nous disposons d’une liste de maladies et pour chaque maladie d’une liste de symptôme
généralement associés (que nous appellerons symptômes typiques). Nous écrivons :
Bi =
1 si le patient a le symptôme de type i0 sinon .
Nous notons D la variable aléatoire associée à la maladie du patient : D ∈ {d1, ..., dk}.
Nous faisons l’hypothèse que le patient ne présente qu’une maladie à la fois ce qui est
une hypothèse raisonnable pour les maladies rares. {D = dk} représente l’évènement pour
lequel le patient est sain ou est atteint d’une maladie qui n’est pas dans la base de données.
Nous disposons d’une estimation de la prévalence de chaque maladie, ainsi que de la
probabilité de présenter chaque symptôme typique sachant la maladie.
Nous connaissons donc P[D = dj ] abrégé en P[Dj ] et également P[Bi = 1 | D = dj ]
abrégé en P[Bi | Dj ] lorsque Bi est un symptôme typique de Dj . Ajoutons qu’il est
possible d’avoir une maladie et de présenter un symptôme atypique mais nous n’avons pas
d’estimation pour de tels évènements. Nous supposerons que les symptômes atypiques
se manifestent avec une faible probabilité (fixée à 10−5) et indépendamment des autres
symptômes (conditionnellement à la maladie).
Un élément important est que nous ne disposons pas des lois jointes des symptômes
sachant la maladie mais seulement des marginales. Nous abordons cette difficulté dans le
chapitre 4.
Actuellement, notre base de données référence 81 maladies et 220 symptômes différents.
La maladie qui présente le plus grand nombre de symptômes associés est le syndrome
VACTERL, avec 19 symptômes possibles.
Toutes ces informations, que nous désignons dans la suite sous le terme de données
expertes, nous ont été fournies par des médecins de l’hôpital Necker-Enfants malades en
se basant sur la littérature disponible.
Dans la suite nous utiliserons de manière indistincte les termes de syndrome, pathologie
ou maladie. De même les termes symptômes, anomalies et signes seront également utilisés
de manière équivalente dans ce travail. Conformément à la définition du Larousse nous
entendons par syndrome un ensemble de plusieurs symptômes en rapport avec un état
pathologique donné et permettant, par leur groupement, d’orienter le diagnostic.
Il s’agit là de la manière classique de représenter informatiquement le concept de
maladie bien que cette approche ne soit pas sans difficulté notamment lorsque la frontière
entre le sain et le pathologique est brouillée Fagot-Largeault [1985].
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1.2.2 Confrontation à des bases plus générales et extraction de
l’arborescence des signes
A notre connaissance, il n’existe pas de base telle que la notre en libre accès, c’est-à-
dire une base composée d’une liste de syndromes rares avec la liste des signes associés
observables à l’échographie.
La base en libre accès la plus proche de ce que nous désirons est sans doute celle
d’OrphaData 3. Cette base de données sur les maladies rares et orphelines est mise à dis-
position par Orphanet, un organisme créé en France par l’INSERM en 1997 et aujourd’hui
soutenu par l’Union Européenne avec une quarantaine de pays partenaires.
Cette base de données n’est toutefois pas directement exploitable en tant que telle pour
notre problème car elle ne se limite pas à l’obstétrique. Ainsi de nombreux signes de la
base ne sont pas observables à l’échographie et beaucoup de syndromes ne sont observables
qu’en néonatal.
Nous avons commencé par mettre les symptômes de notre base initiale en correspon-
dance avec ceux de la base Human Phenotype Ontology (HPO) Köhler et al. [2017]. HPO
est un travail récent qui fournit une terminologie standardisée des anomalies phénotypiques
retrouvées dans les pathologies humaines. Nous nous en sommes servis pour harmoniser
la terminologie.
Nous avons ensuite mis cette liste de symptômes par maladie en correspondance avec
OrphaData. Cela nous a permi d’imputer les valeurs manquantes de notre base ini-
tiale pour les prévalences des symptômes dans les maladies. En effet, OrphaData fourni
l’information pour chaque signe sachant la maladie s’il est obligatoire (100% des cas), très
fréquent (entre 80 et 90% des cas), fréquent (entre 30 et 79%) ou occasionnel (entre 5 et
29%). Lorsque notre base initiale avait une valeur manquante nous avons imputé la valeur
médiane de la fourchette proposée par OrphaData. Lorsque notre base initiale comportait
déjà une valeur pour la prévalence du symptôme dans la maladie nous l’avons conservée
sans inclure la prévalence d’OrphaData.
Il nous a également été possible d’extraire de HPO l’information sur l’ontologie des
symptômes de notre base. Par ontologie nous entendons ici le fait qu’un symptôme donné
puisse être décrit à divers niveau de granularité: par exemple "anomalie cardiaque" est
un ascendant de "Tétralogie de Fallot" (qui est une anomalie cardiaque spécifique). Notre
outil d’aide à la décision doit être capable d’intégrer ce type de raisonnement classique en
médecine (voir le chapitre 5 pour plus de détail).
Actuellement la base de données OrphaData est utilisée pour ajouter de nouveaux syn-
dromes et leurs symptômes associés afin d’enrichir notre base initiale. Une telle opération
nécessite une expertise médicale afin de déterminer les maladies et symptômes à conserver
de la base OrphaData, i.e les symptômes observables à l’échographie.
Mentionnons enfin l’existence d’une autre base de données: EUROCAT. Celle-ci est
3. Disponible sur http://www.orpha.net. Consulté le [02/10/2018].
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le résultat d’un projet à l’échelle européenne visant depuis 1979 à assurer la surveillance
épidémiologique des anomalies congénitales. Le taux de couverture de cette base est rela-
tivement élevée puisque pas moins de 29% des naissances en Europe sont recensées. Cette
base nous sera utile pour obtenir les taux de diagnostic des différentes anomalies durant
le diagnostic prénatal : certaines malformations sont en effet plus difficiles à observer que
d’autres à l’échographie et il peut être intéressant d’incorporer cette information à notre
outil.
1.2.3 Données cliniques
Comme dans de nombreuses applications médicales l’accès à des données cliniques est
difficile. Notre outil d’aide à la décision a cependant vocation à collecter des données au
fur et à mesure de son utilisation. Ces données devront nous permettre de mieux inférer
la loi de notre environement initialisé par les données expertes.
De manière générale nous espérons que ce travail constituera une opportunité de bâtir
une base de données globalisée permettant de mieux connaître les maladies rares diagnos-
ticables par échographie foetale.
1.3 Le besoin médical
L’effort visant à la construction d’un outil d’aide à la décision pour le diagnostic prénatal
apparaît pertinent pour plusieurs raisons que nous évoquons ici.
1.3.1 Amélioration du taux de détection des maladies rares
Notre base initiale comporte 81 maladies rares, mais l’objectif final est de pouvoir fournir
une aide au diagnostic pour environ 1000 pathologies rares différentes. Le nombre de signes
observables à l’échographie est encore beaucoup plus grand. Il est bien évident qu’aucun
médecin ne peut avoir la connaissance encyclopédique d’envisager tous les diagnostics.
La figure 1.3 recense les taux de diagnostic par le dépistage anténatal d’un certains
nombres de malformations congénitales. Si certaines anomalies sont presque systéma-
tiquement diagnostiquées avant la naissance (par exemple une anencéphalie ou encore une
agénésie rénale bilatérale) d’autres sont en situation de sous-diagnostic. Ainsi le taux de
diagnostic des anomalies non détectables par test génétique lors du diagnostic prénatal est
seulement de 39% d’après cette étude d’EUROCAT. Il ne faut bien sûr pas conclure que
les 61% des anomalies congénitales non diagnostiquées auraient toutes pu être observées
en anténatal. En effet, certaines anomalies peuvent ne pas être détectables du tout ou très
difficilement durant l’échographie. Cela est dû aux limitations même de cette technique ou
encore à la nécessaire inégalité des niveaux d’expertises des différents praticiens. La figure
1.4 montre bien l’hétérogénéité des taux de diagnostics d’anomalies congénitales selon les
différentes régions de l’Europe.
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Figure 1.3 – Taux de diagnostic par le diagnostic prénatal de plusieurs malformations
congénitales. Source: données EUROCAT se basant sur des registres européens de l’année
2012 à l’année 2016 (voir le détail des registres concernés dans la figure).
Un outil d’aide à la décision tel que nous cherchons à le concevoir ici, doit permettre
au praticien de se focaliser plus rapidement sur les régions anatomiques à risque et ainsi
d’accompagner les médecins dans l’effort de minimisation du risque de faux négatif. L’outil
final pourra également avoir une fonction de formation, notamment auprès des jeunes
praticiens, en décrivant de manière succinte les anomalies à aller observer.
1.3.2 Rassurer les patients (et les médecins) en cas d’examen normal
Un certains nombres d’anomalies sont très courantes et bénignes si elles apparaissent de
manière isolée. Citons par exemple les pieds bots, une anomalie congénitale orthopédique
touchant une à deux naissances sur 1000 en France qui peut-être corrigée sans trop de
complications à la naissance. Cependant si cette malformation est associée à d’autres
anomalies phénotypiques alors il est à craindre que le foetus soit affecté d’un syndrome
rare d’origine génétique. Si le signe d’appel est "pied bot", notre outil d’aide à la décision
doit permettre aux praticiens de rapidement se focaliser sur les zones à risque. Si le
praticien n’observe pas d’autres anomalies il pourra rassurer les patients et éviter des
examens supplémentaires inutiles.
Ce cas de figure avec un signe d’appel courant qui se révèle après l’examen être isolé
et donc bénin est heureusement le plus fréquent en pratique.
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Figure 1.4 – Taux de diagnostic par le diagnostic prénatal des malformations congénitales
selon les pays. Source: données EUROCAT se basant sur des registres européens de
l’année 2012 à l’année 2016.
1.3.3 Mieux orienter les patients vers des tests génétiques si nécessaire
Si, par malheur, le praticien observe une conjonction d’anomalies il pourra plus rapidement
et mieux orienter la patiente vers des examens complémentaires.
Un diagnostic précoce est toujours préférable, qu’il soit possible de corriger la mal-
formation par chirurgie in foeto (sans attendre de dégradation plus importante) ou non
et qu’une IMG soit à envisager. L’intensité de la détresse psychologique des patients est
en effet intimement liée au terme de la grossesse. La figure 1.5 montre qu’une partie non
négligeable des malformations congénitales diagnostiquées le sont en fin de grossesse: 23%
pour le registre EUROCAT de Paris.
1.4 Contributions et organisation du manuscrit
Dans cette thèse nous avons fait le choix de présenter les sujets abordés par groupe thé-
matique mélant ainsi tout au long du texte nos contributions à celles de la littérature
existante. Afin de faciliter la tâche des rapporteurs nous avons ajouté le symbole © devant
les sections présentant une de nos principales contributions.
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Figure 1.5 – Taux de diagnostic par le diagnostic prénatal des malformations congénitales
selon les pays et les termes de la grossesse. Source: données EUROCAT se basant sur des
registres européens de l’année 2012 à l’année 2016.
1.4.1 Livrable
Le but de cette thèse est de construire un outil d’aide au diagnostic pour la recherche de
maladies rares par échographie foetale. Il s’agit en direct durant l’examen échographique
d’ordonner les différents symptômes possibles dans un ordre décroissant de pertinence,
dans un sens que nous préciserons bientôt. Il s’agit également de fournir en temps réel la
probabilité de chaque maladie étant donné les signes renseignés par l’utilisateur.
La figure 1.6 donne un aperçu de l’outil d’aide à la décision dans la version beta de
son interface. Au départ la population "autre" est de loin la plus probable, il s’agit du cas
de figure où le patient n’a aucune des maladies référencées dans notre base de données :
il peut donc être sain ou affecté d’une maladie qui n’appartient pas à la base.
Nous commençons avec l’absence du signe "hypertélorisme" qui en tant que telle n’est
pas très informative et l’éventualité d’appartenir à la population "autre" reste donc large-
ment la plus probable (probabilité de 99, 8/100). L’information que les oreilles sont situées
anormalement bas fait suspecter un syndrome de Noonan (probabilité 73, 4/100). La
majorité des signes suivant proposés sont typiques de Noonan mais l’absence d’un signe
fréquent chez ce syndrome, spécifiquement le signe "hydrothorax", va réequilibrer les prob-
abilités, rendant plus plausibles les autres syndromes possibles tels que "Apert", Crouzon"
etc qui ont une prévalence plus faible dans la population générale. C’est finalement la
présence d’une cryptorchidie qui permet de soupçonner fortement un syndrome de Noo-
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nan.
Nous présentons ici les différentes problématiques mathématiques qui ont émergé au
cours de ce projet et qui constituent les thématiques abordées dans cette thèse.
1.4.2 Chapitre 2: L’optimisation de prise de décision séquentielle
La première question porte à s’interroger sur la manière de quantifier la pertinence des
différents symptômes à aller consulter. Que cherchons-nous à optimiser ?
La tentative d’optimiser les stratégies de diagnostic en médecine n’est pas nouvelle. Le
problème d’optimisation est généralement formulé sous la forme d’une minimisation d’un
compromis entre le coût des tests médicaux et le coût d’un éventuel mauvais diagnostic.
Dans cette thèse nous proposons plutôt de minimiser le nombre de tests médicaux
nécessaires pour atteindre un état où l’incertitude concernant la maladie du patient est
inférieure à un seuil prédéterminé. Ce faisant, nous tenons compte de la nécessité dans de
nombreuses applications médicales, d’éviter autant que possible, tout diagnostic erroné.
Pour résoudre cette tâche d’optimisation, nous étudions plusieurs algorithmes
d’apprentissage par renforcement et les rendons opérationnels pour notre problème de
très grande dimension: les stratégies apprises se révèlent bien plus performantes que des
stratégies gloutonnes classiques.
Pour ce faire, nous avons divisé la tâche initiale en plusieurs sous-tâches et nous avons
appris une stratégie pour chaque sous-tâche. Nous avons prouvé qu’une utilisation appro-
priée des intersections entre les sous-tâches peut significativement accélérer la procédure
d’apprentissage.
1.4.3 Chapitre 3 : Mélanger experts et données
Pour résoudre notre problème d’optimisation et ainsi apprendre notre stratégie de diagnos-
tic il nous faut construire un modèle de l’environnement. Il n’est en effet pas envisageable
de déployer dans la vie réelle un algorithme non encore optimisé. De plus le nombre de
données cliniques pour les maladies rares est nécessairement limité, c’est pourquoi nous
ne pouvons construire notre modèle en se passant des connaissances expertes disponibles.
La deuxième question mathématiques soulevée dans cette thèse est donc celle de
l’estimation de la loi jointe des symptômes sachant les maladies. Pour ce faire nous dis-
posons de données expertes (sous la forme de marginales et de règles) ainsi que de données
cliniques recueillies au fur et à mesure de l’utilisation de notre algorithme.
Nous étudions plusieurs manières de combiner modèle expert et modèle empirique.
L’idée générale est que si nous avions suffisemment de données nous n’aurions plus besoin
des experts et inversement en l’absence de données notre modèle doit reposer entièrement
sur les experts. Nous nous intéressons dans cette thèse au régime intermédiaire où nous
n’avons pas assez de données pour nous passer des données expertes mais suffisemment
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Figure 1.6 – A demonstration of the current decision support tool diagnosing a Noonan
syndrom
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pour les corriger si nécessaire, i.e si nous observons une distorsion entre les experts et
l’expérience.
Nous proposons d’estimer la loi jointe des symptômes sachant la maladie en choisissant
la distribution la plus proche des experts, au sens d’une mesure de dissimilarité adéquate,
qui soit consistante avec les données empiriques.
Nous prouvons qu’un estimateur définit de la sorte peut, pour une mesure de dissimi-
larité reposant sur une norme ou sur une divergence de Kullback-Leibler, s’écrire comme
une combinaison linéaire des deux modèles : expert et empirique. Cette propriété nous
fournit un algorithme simple et efficace pour calculer notre estimateur.
Nous montrons finalement, tant théoriquement qu’empiriquement, que notre estima-
teur est toujours plus performant que le meilleur des deux modèles (expert ou données) à
une constante près.
1.4.4 Chapitre 4 : Intégrer des raisonnements ontologiques tout en
restant dans le cadre probabiliste
La dernière thématique abordée dans cette thèse n’est pas la moins importante pour la
réussite pratique du projet. Il s’agit de complexifier quelque peu le tableau présenté plus
tôt en intégrant à notre outil d’aide au diagnostic la possibilité pour le praticien de fournir
des réponses à différents niveaux de précision pour les questions posées sur les symptômes.
En effet, en médecine un symptôme peut-être décrit à divers niveau de précision. Ainsi
le terme "hypoplasie du ventricule gauche" est une dénomination plus précise contenue dans
le terme "anomalie du ventricule gauche" qui lui-même est contenu dans le terme "anomalie
cardiaque".
La connaissance des relations entre les différentes terminologies des anomalies mor-
phologiques est représentée sous forme d’une arborescence appellée ontologie. Dans cette
arborescence nous distinguons deux types de relation entre anomalies : ascendant et de-
scendant. Ainsi "anomalie cardiaque" est un ascendant d’ "anomalie du ventricule gauche"
alors que la relation inverse est une relation de descendant.
Nous proposons une méthode pour faire de manière efficace les mêmes opérations de
calcul des probabilités des maladies étant donné une liste de symptômes et de propositions
des prochains symptômes à aller consulter, lorsque les informations sur les symptômes
observés sont à différents niveaux de granularité dans l’ontologie.
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Chapter 2
INTRODUCTION
Abstract: In order to set the scene, we begin with a brief overview
of the world of prenatal diagnosis by discussing the issues, the actors
and the techniques involved. We then discuss the data available and the
information we have been able to obtain from the various existing open
access databases for rare diseases. We continue by explaining the current
need of ultrasound users for a decision support tool and at the same time
specifies the desirable properties that our final algorithm must have. We
end by trying to step back and formulate the more general mathematical
questions that are addressed in this thesis.
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The work presented in this thesis is the result of my three years of research under the
supervision of my two thesis directors, Erwan Le Pennec and Stéphanie Allassonnière, on
a subject at the mathematical/medicine interface.
The objective of this project is to provide prenatal diagnostic practitioners with a
decision support tool to assist them in the search for rare diseases by ultrasound.
My work during these three years was part of a multidisciplinary team that included
mathematicians, Erwan, Stéphanie and myself, obstetricians, Julien Stirnemann, Em-
manuel Spaggiari and Yves Ville, as well as a public health specialist, Antoine Neuraz.
2.1 Prenatal screening and diagnosis
2.1.1 Issues in prenatal diagnosis
France registers approximately 780, 000 births each year, including 39, 000 in the Paris
region alone, and it is estimated that 3 to 4 percent of these pregnancies are affected by
at least one congenital anomaly (see Khoshnood B [2016]).
Congenital anomalies are a major cause of infant mortality: 21% of deaths in the first
year of life are attributable to such anomalies according to the Institut de veille sanitaire 1.
They also represent a significant part of disabilities.
It is therefore clear that the congenital malformations are a public health issue. How-
ever, if the existence of a congenital anomaly is a relatively frequent event, the large number
of possible different pathologies, many of which are rare diseases, makes the obstetrician’s
mission difficult.
2.1.2 Tools that can be used for prenatal diagnosis
Ultrasound, because it is a non-invasive and inexpensive technique, remains the preferred
tool for prenatal screening. In France, the pregnant woman is required to undergo three
ultrasound examinations for control at 12, 21, then 33 weeks of amenorrhea (absence of
menstruation). If an abnormality is detected or suspected, the patient is referred to a
specialist doctor for a second-line ultrasound, also known as a "diagnostic ultrasound".
If a significant risk of chromosomal abnormality (e. g. trisomy 21) is identified, an
amniocentesis should be offered to the mother. Amniocentesis is the removal of amniotic
fluid by abdominal puncture. The study of fetal cell karyotype should provide a reliable
1. http://invs.santepubliquefrance.fr//Dossiers-thematiques/Maladies-chroniques-et-traumatismes/
Malformations-congenitales-et-anomalies-chromosomiques. Accessed[04/03/2019]
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diagnosis of the suspected chromosomal abnormality. It is performed around the 17th
week of amenorrhea. This intrusive technique has long been considered to be risky for the
fetus, the 1% figure of increased risk of miscarriage attributed to amniocentesis has long
been advanced. However, a recent study by Necker doctors showed, in randomized trials
on 2051 women, that using current techniques there is no statistically significant increase
in the risk of miscarriage Malan et al. [2018]. However, this examination is more expensive
and complex than an ultrasound and is therefore not routinely used for screening.
In addition, it should be stressed here that amniocentesis can only detect syndromes
with well known karyotype abnormalities, which is far from being the case for all rare
diseases. These considerations explain the choice of syndromes selected for our database
(see section 2.2): they must be syndromes for which there is not already a reliable and
risk-free way to identify them.
Finally, there are magnetic resonance imaging (MRI) and computed tomography (CT)
examinations. These examinations are performed following a diagnostic ultrasound when
it reveals an abnormality. They must allow "the study of certain organs or structures of
the foetus or of its annexes in a different and complementary way to ultrasound. The most
common anatomical regions explored on MRI are the central nervous system, thorax and
abdomen of the fetus. CT explores the fetal skeleton." 2
It should therefore be noted that ultrasound is particularly important in prenatal
screening since it is systematically used routinely. It is also the best solution for diag-
nosing a certain number of malformations. Indeed, as recalled in the decree of 20 April
2018 on good practices in prenatal diagnosis: "fetal ultrasound is in some cases the only
examination that can identify a risk for the fetus or the current pregnancy, to diagnose a
fetal or obstetrical pathology and monitor it".
2.1.3 The actors involved
As specified in article 1 of the decree of 2 May 2017 (2017-702), in France only "midwives
and doctors with skills recognised by a diploma" are authorised to carry out obstetrical
and foetal ultrasound examinations. However, the prerogatives of these two trades are not
identical.
Midwives hold a state diploma enabling them to carry out screening (control) ultra-
sound examinations. Diagnostic ultrasounds, on the other hand, are not part of their field
of competence. Their profession is governed by articles L4151 of the Public Health Code.
The doctors qualified to monitor a woman’s pregnancy are obstetricians. When a
serious congenital anomaly is suspected, patients are referred to the Pluridisciplinary
Centres for Prenatal Diagnosis (CPDPN), which numbered 49 on French territory in 2015.
The final diagnosis specifying the nature and severity of the malformation is made by at
2. Extract from Annex 1 of the decree of 20 April 2018 setting out the recommendations for good
practice relating to the procedures to carry out imaging examinations contributing to prenatal diagnosis.
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least two prenatal diagnostic specialists in a collegial manner.
2.1.4 Possible therapeutic solutions
When a congenital malformation is diagnosed, the question of management is raised.
Decision-making is always done in a collegial manner by doctors from different specialties
and in collaboration with the Multidisciplinary Centres for Prenatal Diagnosis. The final
decision always rests, of course, with the parents.
If the condition of the unborn child is identified as particularly serious, i.e. involving a
severe disability without an existing therapeutic solution, a medical termination of preg-
nancy (IMG) is possible up to the last day of pregnancy. This is Article L2213-1 of the
French Public Health Code:
Voluntary termination of pregnancy may, at any time, be practised if two
doctors who are members of a multidisciplinary team certify, after the team
has given its advisory opinion, that either the continuation of the pregnancy
poses a serious threat to the woman’s health or that there is a high probability
that the unborn child will suffer from a particularly serious condition recognised
as incurable at the time of diagnosis.
It should be noted that it is not uncommon for parents to refuse the IMG when the
neonatal vital prognosis is very pessimistic Guibet Lafaye [2009]. In such cases, prenatal
diagnosis will have made it possible to consider in advance the possible palliative care to
be provided to the newborn from birth Charlot [2011].
It is appropriate here to embellish this bleak picture somewhat and to highlight recent
advances in fetal surgery that offer hope for the future. For example, the vital prognosis of
fetuses with transfusion-transfused transfusion syndrome for multiple pregnancies has been
greatly improved with recent advances in fetal surgery. Without intervention, perinatal
mortality is 90 percent and severe neurological sequelae are found in 20 to 40 percent of
survivors. Recent techniques allow the survival of one of the two twins in nearly 80% of
cases and a risk of sequelae in survivors of less than 10% Salomon and Ville [2008]. There
are also possible in-fetal operations for spina bifida malformations: a neural tube closure
defect with a prevalence of one in 2000. It has been proven that this operation significantly
improves the prognosis of the unborn child’s disability compared to the alternative solution
of operating in neonatal care (see Adzick et al. [2011]). In general, it is only when such a
demonstration has been made that fetal surgery is considered a fully justified alternative
since, of course, it is not without risk for the mother and the child it carries. However,
this technique is now safe enough to be offered even in cases of non-lethal malformations
(A Deprest et al. [2010]).
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2.1.5 Criminal liability issues
We do not, of course, claim to provide an exhaustive overview of the criminal liability
issues raised by prenatal diagnosis. The reader will easily imagine how complex and ever-
changing these issues can be.
In France, two separate state agencies have been created to settle disputes between
patients and caregivers in order to offer a quick and free alternative to litigation. These are
the Conciliation and Medical Accident Compensation Commission (CCI) and the National
Office for Medical Accident Compensation (ONIAM). The ICC’s function is to provide
expertise for the establishment of potential liability of the caregiver or health facility.
More specifically, ONIAM’s mission is to organise the compensation system.
If liability is established by the ICC, the health professional’s insurer must make a
proposal for compensation that will be accepted or refused by the victim, in the event of
refusal the victim must turn to the competent courts.
The number of complaints sent to the ICC has been steadily increasing since the 2000s
(see figure 1.1). Obstetrical gynaecology is one of the specialities for which the costs of
legal compensation are the highest. The Mutuelle d’assurances du corps de santé français
(MACSF) publishes its annual report on compensation procedures and, in 2017, obstetrics
and gynaecology came in third place with almost 6 million euros in compensation (see
figure 1.2).
2.2 The available data
2.2.1 An initial expert database
We have a list of diseases and for each disease a list of generally associated symptoms
(which we will call typical symptoms). We write :
Bi =
1 if the patient has the symptom of kind i0 otherwise .
We note D the random variable associated with the patient’s disease: D ∈ {d1, ..., dk}. We
assume that the patient has only one disease at a time, which is a reasonable assumption
for rare diseases. {D = dk} represents the event for which the patient is healthy or has a
disease that is not in the database.
We have an estimate of the prevalence of each disease, as well as the probability of
presenting each typical symptom given the disease.
We therefore know P[D = dj ] abbreviated in P[Dj ] and also P[Bi = 1 | D = dj ]
abbreviated in P[Bi | Dj ] when Bi is a typical symptom of Dj . Let us add that it
is possible to have a disease and to present an atypical symptom but we do not have
an estimate for such events. We will assume that atypical symptoms occur with a low
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probability (set at 10−5) and independently of other symptoms (conditionally related to
the disease).
An important element is that we do not have the joint distributions of symptoms given
the disease but only the marginals. We discuss this difficulty in the chapter 4.
Currently, our database references 81 diseases and 220 different symptoms. The disease
with the highest number of associated symptoms is VACTERL syndrome, with 19 possible
symptoms.
All this information, which we refer to as expert data in the following, was provided
to us by doctors at Necker-Enfants Malades Hospital based on the available literature.
In the following we will use the terms syndrome, pathology or disease indistinctly.
Similarly, the terms symptoms, anomalies and signs will also be used in an equivalent way
in this work. In accordance with the Larousse definition, we define a syndrome as a set
of several symptoms related to a given pathological condition and allowing, through their
grouping, to guide the diagnosis.
This is the classic way of representing the concept of disease for a computer, although
this approach is not without its difficulties, especially when the boundary between healthy
and pathological is blurred Fagot-Largeault [1985].
2.2.2 Confrontation à des bases plus générales et extraction de
l’arborescence des signes
To our knowledge, there is no such basis as ours in free access, i.e. a basis composed of a
list of rare syndromes with the list of signs associated with ultrasound.
The closest open access base to what we want is probably OrphaData 3. This database
on rare and orphan diseases is made available by Orphanet, an organisation created in
France by INSERM in 1997 and now supported by the European Union with some forty
partner countries.
However, this database is not directly exploitable as such for our problem because it
is not limited to obstetrics. Thus many signs of the base are not observable on ultrasound
and many syndromes are only observable in neonatal.
We started by mapping the symptoms from our initial database with those from the
Human Phenotype Ontology (HPO) database Köhler et al. [2017]. HPO is a recent work
that provides a standardized terminology of phenotypic abnormalities found in human
pathologies. We used it to harmonize terminology.
We then mapped this list of symptoms by disease with OrphaData. This allowed us
to impute missing values from our initial database for symptom prevalence in diseases.
Indeed, OrphaData provides information for each sign given the disease if it is mandatory
(100% of cases), very frequent (between 80 and 90% of cases), frequent (between 30 and
79%) or occasional (between 5 and 29%). When our initial base had a missing value we
3. Available on http://www.orpha.net. Accessed on [02/10/2018].
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imputed the median value of the range proposed by OrphaData. When our initial base
already included a value for the prevalence of the symptom in the disease, we retained it
without including the prevalence of OrphaData.
It was also possible for us to extract from HPO the information on the ontology of
symptoms of our database. By ontology we mean here that a given symptom can be
described at various levels of granularity: for example, "cardiac anomaly" is an ascendant
of "Tetralogy of Fallot" (which is a specific cardiac anomaly). Our decision support tool
must be able to integrate this kind of classical medical reasoning (see chapter 5 for more
details).
Currently we use the OrphaData database to add new syndromes and their associated
symptoms to enrich our initial database. Such an operation requires medical expertise to
determine the diseases and symptoms to select from the OrphaData database, i.e. the
symptoms that can be observed on ultrasound.
Finally, we should mention the existence of another database: EUROCAT. This is
the result of a Europe-wide project aimed at epidemiological surveillance of congenital
anomalies since 1979. The coverage rate of this base is relatively high since no less than
29% of births in Europe are recorded. This database will be useful for us to obtain the
diagnosis rates of the different anomalies during prenatal diagnosis: some malformations
are indeed more difficult to observe than others on ultrasound and it may be interesting
to incorporate this information into our tool.
2.2.3 Clinical data
As in many medical applications, access to clinical data is difficult. However, our decision
support tool is intended to collect data as it is used. These data should allow us to better
infer the law of our environment initialized by the expert data.
In general, we hope that this work will provide an opportunity to build a globalized
database to better understand rare diseases that can be diagnosed by fetal ultrasound.
2.3 The medical need
The effort to build a decision support tool for prenatal diagnosis seems relevant for several
reasons that we mention here.
2.3.1 Improving the detection rate of rare diseases
Our initial base includes 81 rare diseases, but the final objective is to be able to provide
diagnostic support for about 1000 different rare diseases. The number of signs that can
be observed on ultrasound is even greater. It is obvious that no doctor can have the
encyclopedic knowledge to consider all diagnoses.
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Figure 1.3 shows the rates of diagnosis by antenatal screening for a number of congenital
malformations. While some anomalies are almost systematically diagnosed before birth (e.
g. anencephaly or bilateral renal agenesis), others are under-diagnosed. Thus the rate of
diagnosis of anomalies not detectable by genetic testing at prenatal diagnosis is only 39%
according to this EUROCAT study. Of course, it should not be concluded that all the 61%
of undiagnosed congenital anomalies could have been observed antenatally. Indeed, some
anomalies may not be detectable at all or very difficult to detect during ultrasound. This
is due to the limitations of this technique itself or to the necessary inequality in the levels
of expertise of the different practitioners. The figure 1.4 clearly shows the heterogeneity
of congenital anomaly diagnosis rates across the different regions of Europe.
A decision support tool such as we are trying to design here should enable the prac-
titioner to focus more quickly on anatomical regions at risk and thus assist physicians in
minimizing the risk of false negatives. The final tool may also have a training function,
particularly for young practitioners, by briefly describing the anomalies to be observed.
2.3.2 Reassure patients (and doctors) in case of normal examinations
A number of anomalies are very common and benign if they occur in isolation. For
example, clubfoot, an orthopedic congenital anomaly affecting between one and two births
in 1000 in France can be corrected without too many complications at birth. However, if
this malformation is associated with other phenotypic abnormalities, then there is a risk
that the fetus may have a rare syndrome of genetic origin. If the call sign is "clubfoot",
our decision support tool should allow practitioners to quickly focus on areas at risk. If
the practitioner does not observe other abnormalities, he or she can reassure patients and
avoid unnecessary additional examinations.
This case, with a frequent call sign that appears after the examination to be isolated
and therefore benign, is fortunately the most frequent in practice.
2.3.3 Better refer patients to genetic tests if necessary
If, unfortunately, the practitioner observes a conjunction of anomalies, he will be able to
refer the patient more quickly and better to additional examinations.
Early diagnosis is always preferable, whether it is possible to correct the malformation
by in-fetal surgery (without waiting for further degradation) or not and whether an IMG
is to be considered. The intensity of patients’ psychological distress is closely related to
the stage of pregnancy. The figure 1.5 shows that a significant part of the congenital
malformations diagnosed are diagnosed at the end of pregnancy: 23% for the EUROCAT
registry in Paris.
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2.4 Contributions and organization of the manuscript
In this thesis we have chosen to present the topics covered by thematic groups, thus mixing
our contributions with those of the existing literature throughout the text. In order to
facilitate the task of the rapporteurs we have added the symbol © in front of the sections
presenting one of our main contributions.
2.4.1 Deliverable
The purpose of this thesis is to build a diagnostic tool for the search for rare diseases
by fetal ultrasound. During the ultrasound examination, we aim at ordering the various
possible symptoms in a decreasing order of relevance, in a sense that we will soon specify.
It is also a question of providing in real time the probability of each disease given the signs
given by the user.
The figure 1.6 gives an overview of the decision support tool in the beta version of its
interface. Initially the "other" population is by far the most likely, it is the case where
the patient has none of the diseases listed in our database: he can therefore be healthy or
affected by a disease that does not belong to the base.
We begin with the absence of the "hypertelorism" sign, which as such is not very infor-
mative and the possibility of belonging to the "other" population therefore remains largely
the most likely (probability of 99.8/100). The information that the ears are abnormally
low suggests Noonan syndrome (probability 73.4/100). The majority of the following pro-
posed signs are typical of Noonan but the absence of a frequent sign in this syndrome,
specifically the sign "hydrothorax", will rebalance the probabilities, making more plausible
the other possible syndromes such as "Apert", Crouzon" etc. that have a lower preva-
lence in the general population. It is finally the presence of cryptorchidism that makes it
possible to strongly suspect Noonan syndrome.
We present here the different mathematical problems that have emerged during this
project and which constitute the themes addressed in this thesis.
2.4.2 Chapter 2: Optimizing Sequential Decision Making
The first question is concerned by how to quantify the relevance of the different symptoms
to be consulted. What are we looking to optimize?
The attempt to optimize diagnostic strategies in medicine is not new. The optimization
problem is usually formulated as a minimization of a trade-off between the cost of medical
tests and the cost of a possible misdiagnosis.
In this thesis we propose instead to minimize the number of medical tests necessary to
reach a state where the uncertainty regarding the patient’s disease is below a predetermined
threshold. In doing so, we take into account the need in many medical applications to
avoid misdiagnosis as much as possible. This led us to formulate the task of optimizing
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symptom checkers as a stochastic shortest path problem.
To solve this optimization task, we study several reinforcement learning algorithms
and make them operable in our high-dimensional setting: the strategies learned are much
more effective than traditional greedy strategies.
To do this, we divided the initial task into several subtasks and learned a strategy for
each subtask. We have proven that appropriate use of intersections between subtasks can
significantly accelerate the learning process.
2.4.3 Chapter 3: Mixing experts and data
To solve our optimization problem and learn our diagnostic strategy, we need to build an
environmental model. It is not possible to deploy an algorithm in real life that has not
yet been optimized. Moreover, the number of clinical data for rare diseases is necessarily
limited, which is why we cannot build our model without the available expert knowledge.
The second mathematical question raised in this thesis is therefore that of the estima-
tion of the joint distribution of symptoms given the disease. To do this, we have expert
data (in the form of marginals and rules) as well as clinical data collected as we use our
algorithm.
We study several ways to combine expert and empirical models. The general idea
is that if we had enough data we would no longer need the experts and conversely in
the absence of data our model must rely entirely on the experts. In this thesis, we are
interested in the intermediate regime where we do not have enough data to dispense with
expert data but enough to correct them if necessary, i.e. if we observe a distortion between
experts and experience.
We propose to estimate the joint distribution of symptoms given the disease by choosing
the distribution closest to the experts, in the sense of an adequate measure of dissimilarity,
which is consistent with the empirical data.
We prove that an estimator defined in this way can, for a measure of dissimilarity
based on a Kullback-Leibler divergence or a norm, be written as a linear combination
of the two models: expert and empirical. This property provides us with a simple and
efficient algorithm to calculate our estimator.
Finally, we show, both theoretically and empirically, that our estimator is always more
efficient than the best of the two models (expert or data) within one constant.
2.4.4 Chapter 4: Integrating ontological reasoning while remaining
within the probabilistic framework
The last theme addressed in this thesis is not the least important for the practical success
of the project. The purpose is to make the modelling presented so far more complex by
integrating into our diagnostic tool the possibility for the practitioner to provide answers
at different levels of granularity for the questions asked about the symptoms.
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Indeed, in medicine a symptom can be described at various levels of precision. Thus,
the term "hypoplasia of the left ventricle" is a more precise term contained in the term
"anomaly of the left ventricle" which itself is contained in the term "cardiac anomaly".
The knowledge of the relationships between the different terminologies of morpholog-
ical anomalies is represented in the form of a tree structure called ontology. In this tree
structure we distinguish two types of relationship between anomalies: ascending and de-
scending. Thus "cardiac anomaly" is an ascendant of "left ventricle anomaly" while the
inverse relationship is a descendant relationship.
We propose a method to efficiently perform the same operations for calculating the
probabilities of diseases given a list of symptoms and proposals for the next symptoms to
consult, when the information on the observed symptoms is at different levels of granularity
in the ontology.
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Chapter 3
Planning Task
Abstract: In this chapter, we propose an optimization formulation for
the task of building a decision support tool for the diagnosis of rare dis-
eases. We aim to minimize the number of medical tests necessary to
achieve a state where the uncertainty regarding the patient’s disease is
less than a predetermined threshold. In doing so, we take into account
the need in many medical applications, to avoid as much as possible,
any misdiagnosis. To solve this optimization task, we investigate sev-
eral reinforcement learning algorithms and make them operable in our
high-dimensional setting: the strategies learned are much more efficient
than classic greedy strategies.
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3.1 A Markov Decision Process framework
3.1.1 Formulation of the optimization problem ©
General framework We can formulate our sequential decision making problem using
the Markov Decision Process (MDP) framework. MDP are widely used for modeling the
decision making process of an agent acting in an uncertain environment, see Bertsekas
[2005], Sutton and Barto [2018]. By uncertain, we mean here that the agent’s actions
randomly affect the environment.
An MDP is composed of a 4-tuple (S,A, T, r) where S is the state space, an element
s of S should encode the available information about the environment valuable for the
decision maker at a given time. A is the action space, it is composed of the actions that
the agent can takes in its environment. More specifically we denote A(s) the set of action
the agent can take in state s.
T (s, a, s′) is the transition function which gives the probability to reach state s′ when
taking action a in state s. The Markov propriety of the MDP allows us to only consider
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the last state s when considering the probability to reach state s′ while taking action a
and not the whole past path followed.
Finally r(s, a) is the reward the agent received when taking action a in state s. The
goal of the agent is to find a way to act in its environment which maximise the expected
amount of reward.
Modelization in our particular problem Concerning the state space S, we use the
ternary base encoding 1 if the considered symptom is present, 0 if it is absent, 2 if non
observed yet. We therefore write
S =
{
(2, . . . , 2), (1, 2, . . . , 2), . . . , (0, . . . , 0)
}
.
An element s ∈ S is a vector of length 220 (the number of possible symptoms), it sums
up our state of knowledge about the patient’s condition: the i-th element of s encode
information about the symptom whose identifier is i. In the following we will denote
st = (sjt )220j=1 the state visited at time t.
Concerning the action space A, we write :
A =
{
a1, ..., a220
}
.
An action is a symptom that we suggest to the obstetrician to look for, more specifically
aj is the action to suggest to check symptom j.
Our transition function T directly use our environment model which is composed of
the joint distributions of the different combinations of symptoms given the disease (see
chapter 4 for more details on the construction of such a model) :
T (st, ai, st+1) =

P[Bi | st] if sjt+1 = sjt for all j 6= i and sit+1 = 1
P[B¯i | st] if sjt+1 = sjt for all j 6= i and sit+1 = 0
0 otherwise .
This equality states that taking a certain action a in a state s we can only reach
two different descendant states depending on the presence or absence of the symptom
to be consulted. To compute this probability P[Bi | st] we can use the Bayes formula
and compute the corresponding probabilities P[Bi, st] and P[st] using the law of total
probability summing over all the possible diseases.
When referring to the events whose probabilities we measure, we will sometimes use
the notation with the symptoms random variables (Bi)i and sometimes use the state s ∈ S.
Note that these notations are in fact equivalent, it is possible to easily switch from states
s to symptom intersections (Bi)i.
Our environment dynamic is by construction Markovian in the sense that:
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P[st+1 | at, st, at−1, st−1, ...a0, s0] = P[st+1 | at, st]
where at is the action taken at time t.
Diagnostic policy We aim to learn a diagnostic policy that associates each state of
knowledge (list of presence/absence of symptoms) with an action to take (a symptom to
check):
pi : S→ A. (3.1.1)
What should be a good diagnostic policy? Many medical applications consider a trade-
off between the cost of performing more medical tests (measuring it in time or money)
and the cost of a mis-diagnosis Zubek and Dietterich [2005], Tang et al. [2016], Kao et al.
[2018].
However in our case the cost of performing more medical tests (i.e to check more
possible symptoms) is negligible against the potential cost of a mis-diagnosis. In theory,
the obstetrician have to check all possible symptoms to ensure the fetus does not present
any disease. Therefore we do not take the risk of a mis-diagnosis by trying to ask fewer
questions. However if the physician observes a sufficient amount of symptoms he can stop
the ultrasound examination and perform additional tests, like an amniocentesis, to confirm
his hypotheses.
This is why we can label some states as terminal: they satisfy the condition that the
entropy of the random variable disease is so low that we have no doubt on the diagnosis.
In this setting, our goal is to minimize the average number of inquiries before reaching a
terminal state:
pi? = arg min
pi
EP
[
I
∣∣s0, pi], (3.1.2)
where s0 = (2, ..., 2) is the initial state, P the law of the environment currently used, pi
the diagnostic policy, and I is the random number of inquiries before reaching a terminal
states, i.e:
I = inf{t | H(D | St) ≤ } (3.1.3)
where
H(D | St) =
∑
st
P[St = st]H(D | St = st)
= −
∑
st
P[St = st]
∑
d
P[D = d | st] logP[D = d | st]
is the entropy of the random variable disease D given what we know at time t: St. We
should think st as a realization of St, this is nothing more than the state we reached for
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one examination on a given patient while St is the associated random variable. For a given
start state s0 and a policy pi there are many possible states that we can reach since the
answers are stochastic.
Note that we are not ensured that for all t we had H(D | st+1) ≤ H(D | st). Never-
theless this inequality holds when taking the average
H(D | St+1) ≤ H(D | St),
see theorem 2.6.5 of Cover and Thomas [2006], "information can’t hurt". In summary,
when we consider that entropy is sufficiently low and that we can stop and propose a
diagnosis, we know that on average, the uncertainty about the patient’s disease would not
have increased if we had continued checking symptoms.
Setting a reward function as follow, ∀st, at:
rt+1 := r(st, at) = −1,
we can rewrite (3.1.2) in the classical form of an episodic reinforcement learning problem
Sutton and Barto [2018]:
pi? = arg max
pi
EP
[
I∑
t=1
rt
∣∣∣s0, pi
]
. (3.1.4)
In the RL community such a reward design is called action-penalty representation,
since the agent is penalized for every action that it executes Barto et al. [1995]. Note that
even though we refer to (3.1.4) as a RL problem, it would be more appropriate to present
it as a planning problem since we assume to know the environment law P (see chapter
4 and Figure 4.1) and aim to solve the MDP associated. Nevertheless, in practice, since
the dimension of our problem is high, we solve the MDP by sampling trajectories and
then treating the environment model as a simulator. This subtlety explains the common
confusion between the terms RL and planning.
3.1.2 Related works.
Non probabilistic symptom checker A symptom checker is an algorithm which takes
a list of observed symptoms as input and output a corresponding list of possible diseases.
There are numerous relevant symptom checker for the diagnostic of rare diseases (in partic-
ular in obstetric) such as for example Orphamizer see Köhler et al. [2009] and Köhler et al.
[2017]. Nevertheless we think that an algorithm operable during the medical examination
would be more useful than an expert system designed for retrospective use.
This is why we aim to propose at each stage of the medical examination the most
interesting symptom to check and to display the probability of each disease. We call such
algorithm dynamic symptom checkers.
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Existing dynamic symptom checker Numerous dynamic symptom checker are freely
available online. Let us cite for example SymCat 1 a dynamic symptom checker developed
for patient self-use. However SymCat, like most of the symptom checker, does not have
any academic communication associated, it is therefore difficult to compare our work with
theirs.
The goal of such symptom checkers may be to diagnose the disease or to triage patients
determining whether the users should seek care more or less urgently or if self care is
possible.
Although these systems are pretty popular with the public, several of them reports
ten of millions of use each year, their performance are not obvious. A recent study on 23
popular symptom checker and using a sample of 770 standardized patients found that the
correct diagnosis was ranked first in only 34% of the case and that the correct diagnostic
was ranked within the top 20 diagnoses in 58% of the cases, see Semigran et al. [2015].
These symptom checker are generally risk averse, advising users to seek care for conditions
where self care is reasonable. Their effect on patient anxiety is therefore not negligible
Doherty-Torstrick et al. [2016].
The symptom checker that made the most noise in the press these last years is certainly
Babylon, a product of the London start-up Babylon Health. DeepMind founders, a start-
up acquired by Google in 2014, are among the group of investors of this company and they
also benefit from support of the NHS (National Health Service) of Great-Britain. Babylon
Health claimed to obtain better results than general practitioner on the triage task and a
comparable accuracy for the task to identify the disease of the patient, see Razzaki et al.
[2018] for more details on the method used.
Once again there is no much detail on the core of the algorithm tested in Razzaki et al.
[2018]. They only mention that it is based on a probabilistic graphical model and also refer
to their previous paper Middleton et al. [2016]. In Middleton et al. [2016] they represent
the diagnostic procedure with "triggers", i.e. certain combinations of signs trigger a series
of pre-learned questions. This is a good way to reduce the dimension of the problem by
replacing the task of learning the global decision tree by the task of learning several sub-
trees (see figure 2 of Middleton et al. [2016]). They do not provide much more information
on how these triggers node are determined and how the diagnostic strategy starting from
a certain trigger node is learned, they only referred to the classical work of Quinlan [1986]
on optimization of decision trees.
In this thesis, we present a particular way of dividing the global decision tree into
several sub-trees and propose algorithms that take advantage of sub-trees already resolved
to learn the remaining ones, see sections 3.1.3 and 3.4.4.
Moreover as explained in the introduction, our decision support tool is designed to be
used by physicians, it should not increase patient anxiety but rather reduce it by offering a
1. http://www.symcat.com/
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second perspective and reducing the number of ultrasounds to be performed. Moreover we
believe that a decision support tool for the physicians is especially useful for the diagnosis
of rare diseases since common disease are easy to diagnose for any physician. Finally
obstetrics is a particular field in the sense that the main person concerned is not able to
describe his or her symptoms.
Algorithm AO? Very few academic works try to address the issue of building a dynamic
symptom checker. We reference Zubek and Dietterich [2005] which proposed an algorithm
inspired of AO? algorithm.
AO? algorithm is a variant of the famous A? algorithm for finding minimum cost path
between a start node and a final node trough a graph Hart et al. [1968]. The cost of a path
is defined as the sum of the costs the edge crossed. The algorithm works by maintaining
a tree of paths originating at the start node and extending those paths one edge at a time
until its stopping criterion is satisfied (see figure 3.1). At each step it consider all the
current node n yet expanded and expand the one which minimize :
f(n) = g(n) + h(n) (3.1.5)
where g(n) is the cost of the path from the start node to node n and h is an heuristic
function which estimates the cost of the cheapest path from n to the goal. As long as h is
an admissible heuristic, i.e it does not overestimate the costs to reach the node goal, A?
is guaranteed to converge toward the least-cost path.
Our problem is related to A? algorithm as we aim to find the shortest path of our
graph between a given start node and a certain class of terminal nodes. The admissible
heuristic proposed by Zubek and Dietterich [2005] consists in making a two-step look-
ahead. This approach should allow to save computational resources by not exploring part
of the decision trees which appears really bad.
Note that such an approach is not tractable in a high-dimensional graph like ours.
Indeed an A? algorithm assume the possibility to store the whole tree of the paths inves-
tigated.
Some improvements of A? have been proposed as for example in Korf [1985] with the
algorithm known as IDA?. Such an algorithm provides the same guarantee as A? to find
the shortest path while using less memory. It consists in cutting off a branch when its total
cost (see equation (3.1.5)) exceeds a given threshold. This threshold is updated over the
iterations of the algorithm. IDA? needs less memory than A? because it only remember
the nodes of the current path, requiring a linear amount of memory in the length of the
solution that it constructs.
However, this algorithm does not exactly match our problem. In fact, in our case,
we are not looking for a single shortest path in a deterministic graph, but rather to find
for each node of the graph the shortest path to the objective states. Indeed, since we
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Figure 3.1 – Example of the iteration of an A? algorithm on a simple graph.
allow the doctor to answer a different answer than the one we propose, we want to have
a good solution even in a part of the tree that is not the optimal path. In this sense we
cannot avoid using some form of policy parameterization, so we have the hope that a good
solution on the optimized part of the tree will have learned a good enough representation
of the state to be good on the invisible part of the tree.
Decision tree optimization Note that in a certain sense our problem can be likened
to a decision tree optimization task where the features are the symptoms and the disease is
the target. Indeed a policy on a MDP is a generalization of a tree, a policy being less rigid
in that sense that it can still propose the next feature to check when the physician made
a different choice to the one we proposed. Classic decision tree algorithms, see Breiman
et al. [1984] or Quinlan [1986], rely on optimizing an impurity function, the entropy or
Gini index of the target random variable, in a greedy way.
Some works as Kortum et al. [2017] proposed to use this algorithm to build a dynamic
symptom checker, it chooses to ask the question about the symptom which minimizes the
average entropy of the disease. However note that such an algorithm is greedy and is
therefore subject to the well-known horizon effect Berliner [1973], an action that appears
to be good in horizon 1 may turn out to be bad in a more distant horizon. See section
3.1. A Markov Decision Process framework 51
3.3.1 for more details.
Thus recent works looking for global optimization procedure of decision trees such as
Bertsimas and Dunn [2017] can be seen as relevant. However, once again, these algorithms
using MIO (Mixed Integer Optimization) solvers cannot cope with our high-dimensional
problem. Indeed the complexity of such algorithms is n × 2D where n is the number of
data and D the maximal depth of the tree. Nevertheless in our case we can not restrict
that easily the maximum allowed tree depth since in the worst case, the physician will not
observe any symptom and will then have to check them all.
20 questions game Our problem is somewhat related to the old well-known 20 questions
game. In this game one of the two players chooses a subject (a famous person, an animal)
and does not reveal it to the other. Then the questioner tries to guess the subject by
asking 20 questions. Some recent works proposed a reinforcement learning approach to
train a questioner algorithm for such kind of game Hu et al. [2018], Zhao and Eskénazi
[2016].
In some sense we could see our problem as a 20 questions games, asking question about
symptoms to guess the disease. There are nevertheless several notable differences between
our problem and a classical 20 question game. First note that in a 20 question game there
is a fixed budget of question and that therefore the reward design is different. We do not
set ourselves a question budget as it would not be ethical in medicine to do so (to set
the examination duration to 10 minutes for example). Then note that the transitions are
deterministic in a 20 question games which makes it significantly easier comparing to our
stochastic transitions since there is less variance in the returns.
In Hu et al. [2018] the authors propose an interesting alternative approach to modelize
the states of the MDP. Instead of representing states as a vector of digit where each number
corresponds to a symptom, the state is a vector of the current probabilities of each disease.
It is difficult to judge a priori which representation is the most suitable. Note that there is
a loss of information when transforming the state from the presence/absence of symptoms
to the probabilities of the diseases. Indeed if the list of presence/absence of symptoms
directly give the probabilities of the diseases the reverse path is less obvious as different
combinations of symptoms can give the same disease distribution. In practice the questions
already asked are memorized so as to avoid to propose symptoms which have been checked
yet but only the current probabilities of the disease are given to the neural network. Note
that this loss of information might have some unfortunate consequence in some specific
cases. We can imagine for example two different combinations of presence/absence of
symptoms, say (B1, B2) and (B2, B3), that might give the same disease distribution but
that in the first case the most discriminant question to ask would be B4 when B4 is actually
incompatible with B3. Thus a policy trained with such a state representation would have
to take a sub-optimal action in one of the two cases.
Otherwise these two different alternative do not appear easy to decide between and a
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careful empirical comparison is needed. It is not obvious that the approach of Hu et al.
[2018] would reduce that much the dimension of the state space but we could argue that
the continuing aspect of the disease distribution input would be preferable to the discrete
nature of our input (we add an embedding layer to our neural network to face this issue).
This is a common issue in applications of reinforcement learning to be concerned on
the feature engineering of the state signal. A good state representation has to satisfy
several conditions. First if we want to remain in the MDP framework, the state should
only include information that we can observe in real life, otherwise a partially observable
Markov decision process (POMDP) must be considered, see Kaelbling et al. [1998]. A
second condition is to respect the Markov propriety, for example in the paper of Mnih
et al. [2013] the authors had to complexify the first idea for the state representation that
would take the raw pixel image to learn Atari with RL algorithms : they took the last
4 images to ensure that the Markov propriety is respected. A last more fuzzy rule is to
provide enough information about the state so as to learn good policies without providing
too much unnecessary information which will have to force the neural network to remove it
itself. Some recent works focus on automatically learning an efficient state representation
and to integrate this learning to the training process de Bruin et al. [2018].
It is also interesting to note that the strategies learned in Hu et al. [2018] by training a
neural network does not appears to outperform a solution based on entropic minimization
ideas (following the ideas of classical algorithm for the decision tree construction). It
strengthens our observations presented later that the entropic baseline is often a good
solution. Nevertheless we prove empirically in several sub-tasks that a neural network
trained with reinforcement learning algorithms can be more effective that this baseline in
our problem.
Finally we note that there are some problematic aspects to the work of Hu et al.
[2018] that encourages us to take their numerical results with caution. Among these
aspects let us cite the fact that they propose to employ a neural network to estimate the
immediate rewards of their actions. Nevertheless it is, for obvious reason, problematic to
learn simultaneously the rewards and the strategy of the agent. The objective of learning
the reward signal is formulated differently in the literature, it can be presented as the
objective of learning from expert human demonstrations (the agent strategy is therefore
fixed) and is in such case referred as inverse reinforcement learning, see Ng and Russell
[2000]. Some recent work as Agarwal et al. [2019] propose to learn simultaneously the
parameters of what is called auxiliary reward and the policy. Nevertheless the reward
initially designed by the engineer (which is not the auxiliary reward) is not modified and
is still used. Auxiliary rewards are optimized so that the policy learned by maximizing
it on the training set has also achieved high performance on the test set for the initial
reward provided.
From what we have understood, in Hu et al. [2018] it does not seem that there is such
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an anchoring of the learned auxiliary reward on the reward initially designed, which seems
problematic.
Disease diagnostic task using Reinforcement Learning algorithms Recent works
Tang et al. [2016], Kao et al. [2018] and Peng et al. [2018] focus on this problem of building
a symptom checker using reinforcement learning algorithms. Nevertheless our approach is
fairly different to these previous works, both in our way to formulate the objective (and
then in our reward design) than in the solutions that we propose (our ways to deal with
high-dimensional issues).
They formulated their optimization problem as a trade-off between asking less ques-
tions and making the right diagnosis while we formulate it as the task of reaching as quick
as possible, on average, a pre-determined high degree of certainty about the patient dis-
ease. In practice, in our case, the only parameter  to be tuned is the degree of certainty
we want at the end of the examination: we should stop when the entropy of the disease
falls below this threshold. The fewer the  the more symptoms our algorithm will need
before considering that the game ends.
Tang et al. [2016] makes use of a discounted factor γ ∈ [0, 1] in their reward signal
design. They design the reward associated to each question to be zero until possessing
a diagnosis (which is an additional possible action) where the reward is equal to γq (if
the guess was correct, 0 otherwise), q being the number of questions that have been
inquired before possessing the diagnosis. In this context γ makes the compromise between
asking fewer question and making the right diagnosis. The smaller γ, the more likely the
algorithm is to make a wrong diagnosis by trying to ask fewer questions.
Note that Tang et al. [2016] has to perform its learning algorithm while trying several
differents values of γ. On the contrary we can determine which value of  we should take
before launching any learning algorithms. We can indeed interact with the physician,
in a first step, presenting him a sample of states where our algorithm would possesses a
diagnostic. If the physician considers that the algorithm stops too early we should decrease
, otherwise we should increase . This is an advantage since the main bottleneck in terms
of computing time is the learning phase.
Stochastic shortest path Our problem is a particular case of the more general stochas-
tic shortest path problem presented in the book of Bertsekas [2007]. In deterministic
shortest path the goal is to find the shortest path from an initial node (state) to a termi-
nation node of a graph where the cost of a path is measured as the sum of the cost of the
crossed arcs (linking the node).
In the stochastic shortest path the controller assign at each node a probability distribu-
tion to reach all the other node. If these probability distributions all assign a probability
1 to reach an unique successor we then return to a problem of deterministic shortest path.
Our problem is a stochastic shortest path where the structure of the graph is particular
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Figure 3.2 – Visualization of a part of the graph of which we are looking for the shortest
path.
: there are links only between nodes which are at depth levels diverging by 1 (see figure
3.2). Namely if we denote s(k) = (s(k)i )220i=1 and s(l) = (s
(l)
j )220j=1 two different nodes, they
are connected, s(l) → s(k), if an only if it exists h such that s(k)i = s(l)i for all i 6= h
and s(k)h 6= 2 = s(l)h . Thus at each node only a few number of descendants nodes are
directly reachable. These connections are only in one direction, from the ascendant to the
descendant.
The classic formulation of the stochastic shortest path problem considered by Bert-
sekas [2007] consider an infinite horizon undiscounted problem where transition cycles are
possible. Therefore they mainly focus on finding assumptions under which the classic dy-
namic programming algorithms are ensured to converge to the optimal policy. The first
assumption of Bertsekas [2007] is that at least one policy is proper. A policy is said to be
proper if there is positive probability that the destination will be reached after at most
n step regardless of the initial state (where n is the number of non-terminal state/node).
The second assumption is that all improper policies have an infinite cost for at least one
state (a reward −∞). The recent work Bertsekas and Yu [2013] prove that a variation of
the classic dynamic programming algorithms can be shown to converge even by removing
this second assumption.
From this point of view our problem is not theoretically hard as all the policies are
proper and we should see in section 3.2 that it is sufficient to ensure convergence of dynamic
programming algorithms. What makes our problem difficult is the curse of dimensionality
that make many algorithms intractable.
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3.1.3 High-dimensional issues ©
Decomposition of the task using a partition of the state space Our full model is
of very high dimension: we have 220 different symptoms and then theoretically 3220 ≈ 10104
different states. Thus a classical tabular dynamic programming (DP) approach (see section
3.2) is impossible. According to our experiments, a classical Deep-Q learning is also not
numerically tractable (section 3.4).
In order to break the dimension, we capitalize first on the fact that the physicians use
our algorithm mainly after seeing a first symptom. In such case, we make the assumption
that this initial symptom is typical. It might be possible to have a disease which also
presents a non-typical symptom but this happens with a very low probability, sufficiently
negligible for the clinicians. Anyway, in this case, we would end up with a high entropy
and no disease identification. This leads to switch to another strategy. With such an
assumption the dimension drops significantly since we now only consider diseases for which
this initial symptom is typical, the only relevant symptoms are the one which are typical
of these remaining diseases.
Therefore we created 220 tasks Ti to solve. We denote Bi = (Bi1 , ..., Bik) the set of
symptoms related with the symptom i, i.e this is the set of symptoms which are still
relevant to check after observing the presence of symptom i. We denote Si the state set
associated to the task Ti, the elements of Si are of length |Bi|. For an element s = (sj)|Bi|j=1
of Si the m-esima number sm stands for the symptom Bim .
For all i, we start from state s(i) which is the state of length |Bi| with the presence of
symptom Bi and no other information on the others symptoms, and we aim to solve :
pi?(i) = arg max
pi
EP
[
I∑
t=1
rt | s(i), pi
]
. (Ti)
The different sub-problems dimensions, i.e the different values of |Bi|, are displayed in
Figure 3.8. Fragmenting that much our problem as the advantage of giving us a very good
optimized policy on several part of our decision tree that would have been under-optimized
otherwise (because these parts of the tree are not often visited). Of course, optimizing
the parts of the tree that are not often visited is not very useful to reduce our overall
loss function, but it is important to provide, in all cases, a reasonable proposal to the
physician if we want him to have confidence in us. This approach will force us to choose a
learning algorithm which can handle different sub-problems without needing to tune too
many hyper-parameters.
Related works To cope with these high dimensional issues, Tang et al. [2016] proposed
in their first paper to learn a different policy for each of the 11 anatomical parts they
previously built. As they recognized in their second paper Kao et al. [2018] this approach
is problematic. Indeed a symptom may be related to several different anatomical parts.
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How to choose which model to use when observing an initial symptom? In their first paper,
when a patient give an initial symptom, they choose the model with the best accuracy
on their training set and follow this policy until the end of the process. Nevertheless, as
they write in Kao et al. [2018], it is possible that the target disease does not belong to
the disease set of the chosen anatomical part. This is why they proposed to learn another
policy, called master model, which choose at each step the most promising model (among
the 11 anatomical parts) to use.
Concerning Peng et al. [2018] the main idea is to use reward-shaping to face the
sparse-reward issue typical of the symptom-checker optimization. They add an auxiliary
reward when discovering the presence of a symptom. Nevertheless it is well-known that
reward-shaping and Q-value initialization are in fact equivalent, see Wiewiora [2011]. Thus
initializing our algorithms with a reasonable policy (for example the one which greedily
minimize the disease entropy) instead of a random policy would give the same benefits
observed in Peng et al. [2018].
In reinforcement learning, there exist several ways to solve a problem like (Ti). If the
dimension is small enough it is possible to find the optimal solution explicitly using a
dynamic programming algorithm (see section Sutton and Barto [2018], for example using
the value iteration algorithm (see section 3.2). If the number of states is too high we have
to parameterize the policy (policy-based approach, see section 3.3) or to parameterize the
Q-values (value-based approach, see section 3.4). We have investigated both approaches
to solve our problem.
3.1.4 The use of the environment model
Theoretically the environment model that we have at our disposal, the joint distribution
of the combination of symptoms given the disease learned in chapter 4, provides us with
a transition model.
Nevertheless, in practice, we do not use directly the model. It is indeed not possible to
store the transition matrix for dimensional reasons. That is why our only alternative to
solve the optimization problem (3.1.4) is to simulate games by recalculating the transition
probabilities on the fly.
Moreover, the incremental nature of the states implies that the cost for simulating a
game from the start s0 to a certain state st is approximately the same than the cost to do
an unique transition from state st−1 to st. That is why our environment model should be
looked in practice as a simulator of games starting from state s0 to sI .
Finally, note that a subtlety of our stopping criterion (3.1.3) is that it requires us to
compute the probabilities of the diseases given the symptoms combination of the current
state at each step of the medical examination. Indeed for dimensional reasons we can not
store the set of goal states and have to check at each step if we can stop and possess a
diagnostic or not.
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Even though we refer to (3.1.4) as a RL problem, it would be more appropriate to
present it as a planning problem since we assume to know the environment law P and
aim to solve the MDP associated. Nevertheless, as we explained previously, since the
dimension of our problem is high, we solve the MDP by sampling trajectories and then
treating the environment model as a simulator which blurs the boundaries between RL
and planning.
3.2 Dynamic programming algorithm for solving low dimen-
sional sub-tasks
In this section we assume that we have placed ourselves at the level of a tasks Ti sufficiently
low dimensional to solve it with dynamic programming algorithms. We will always drop
the i index for the sake of simplicity even if if we work on a simple sub-task and not on
the entire problem of equation (3.1.4).
3.2.1 The different dynamic programming algorithms
Some notations Let us first define the value function as for all state st:
Vpi(st) = EP
 I∑
t′=t+1
rt′ | st, pi
 .
This is the expected cumulative reward we get starting from state s and using policy
pi. Similarly the state-action function is defined as for all state st and all action at :
Qpi(st, at) = EP
 I∑
t′=t+1
rt′ | st, at, pi
 .
The optimal value at state s, V ?(s) = Vpi?(s) gives the highest achievable expected
return when starting from state s. Similarly Q?(s, a) = Qpi?(s, a). It means that a strategy
is optimal if it achieves the highest expected return in all states.
Bellman equations The main idea of dynamic programming algorithms consist in mak-
ing use of the famous "principle of optimality", namely the tail policy is optimal for the tail
subproblem. In our special area of interest this principle takes the form of the following
Bellman optimality equations for the value functions :
V ?(s) = max
a∈A
{
r(s, a) +
∑
s′
P[s′ | s, a]V ?(s′)
}
(3.2.1)
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and for the state-actions values :
Q?(s, a) = r(s, a) +
∑
s′
P[s′ | s, a] max
a′∈A
Q?(s′, a′).
Defining the Bellman optimality operator T ? : RS → RS as :
(T ?V )(s) = max
a∈A
{
r(s, a) +
∑
s′
P[s′ | s, a]V (s′)
}
we can rewrite the Bellman equation under the more compact following form :
T ?V ? = V ?.
Value iteration algorithm The value iteration algorithm is a point-fix algorithm which
uses the Bellman optimality equation as a recursive update, namely let Vk refer to the
value function estimate at iteration k, the value-iteration algorithm produces the following
sequence of value functions, for all k :
Vk+1 = T ?Vk
where V0 is an arbitrary vector.
Policy Iteration algorithm The policy iteration algorithm starts from an arbitrary
policy pi0 and then alternates two steps until convergence :
• A policy evaluation step (E): compute the value function of each state for the policy
of the k-th iteration Vpik(s).
• A policy improvement step (I): use the value functions of pik to greedily improve it
in a better policy pik+1.
This summarises as:
pi0
E−→ Vpi0 I−→ pi1 E−→ Vpi1 I−→ pi2 E−→ ... I−→ pi? E−→ V ?
Concerning the policy evaluation step we use the recursive equality on value functions:
Vpi(s) = r(s, pi(s)) +
∑
s′
P[s′ | s, pi(s)]Vpi(s′). (3.2.2)
The Bellman operator underlying pi, T pi : RS → RS, is defined by :
(T piV )(s) = r(s, pi(s)) +
∑
s′
P[s′ | pi(s), a]V (s′) (3.2.3)
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and we can then write (3.2.2) under the more compact form :
T piVpi = Vpi.
Then the policy evaluation algorithm of a strategy pi consists in producing the following
sequence of value functions :
Vk+1 = T piVk.
Finally the policy improvement step consists in improving greedily the strategy pi to
obtain a new strategy pi′ :
pi′(s) = arg max
a∈A
Qpi(s, a)
= arg max
a∈A
{
r(s, a) +
∑
s′,r
P[s′ | s, a]Vpi(s′).
}
3.2.2 Proof of convergence
Most of the books of reinforcement learning, Szepesvari [2010], Sutton and Barto [2018]
presents the proofs of convergence of dynamic programming algorithms in the case of
infinite horizon discounted problems, namely the reward are discounted by a factor γ ∈]0, 1[
at each time step :
pi?γ = arg max
pi
EP
[+∞∑
t=1
γtrt | s0, pi
]
. (3.2.4)
The main idea of the proof is to show that the Bellman optimality operator T ?γ
(T ?γV )(s) = max
a∈A
{
r(s, a) + γ
∑
s′
P[s′ | s, a]V (s)
}
is a contraction which is due to the fact that γ ∈]0, 1[. The second point is to note that
the Bellman optimality equations means that V ? is the unique fixed-point of T ?γ . Then
it suffices to use the Banach’s fixed-point theorem to conclude that the value-iteration
algorithm converges toward V ?.
In an undiscounted horizon setting, T ? may be no longer a contraction but the result
still holds, see Bertsekas [2007] (Proposition 1.2), if it verifies the two assumptions that
there is at least one proper policy and that all improper policies have an infinite cost for
at least one state.
In fact as in our case all the policies are proper we have that T ? is a contraction for
a weighted sup-norm. The proof of such a result can be find in Bertsekas and Tsitsiklis
[1996] (proposition 2.2) we outline here the main lines. First the idea is to prove that the
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Bellman operator T pi (see equation (3.2.3)) is a contraction. We use here pi,j(pi(j)) as a
shorthand for P[st+1 = j | st = i, pi(st)], thus ∀i ∈ S, ∀V, V˜ ∈ RS and a vector ψ to be
specified later :
∣∣∣(T piV )(i)− (T piV˜ )(i)∣∣∣ =
∣∣∣∣∣∣
∑
j
pi,j(pi(i))(V (j)− V˜ (j))
∣∣∣∣∣∣
≤
∑
j
pi,j(pi(i))
∣∣∣V (j)− V˜ (j)∣∣∣
≤
∑
j
pi,j(pi(i))|ψ(j)|
max
j
∣∣∣V (j)− V˜ (j)∣∣∣
|ψ(j)|
≤ β|ψ(i)|max
j
∣∣∣V (j)− V˜ (j)∣∣∣
|ψ(j)| (3.2.5)
and then dividing by |ψ(i)| and taking the maximum over i for the left-side of the
inequality we have ‖T piV − T piV˜ ‖ψ,∞ ≤ β‖V − V˜ ‖ψ,∞.
For ψ we set for all i, ψ(i) = V ?(i), and using the inequality
V ?(i) = −1 + max
a
∑
j
pi,j(a)V ?(j)
≥ −1 +
∑
j
pi,j(pi(i))V ?(j)
we have
∑
j
pi,j(pi(i))ψ(j) ≤ ψ(i) + 1 ≤ βψ(i) where β = maxi ψ(i) + 1
ψ(i) .
Note that for all i, ψ(i) ≤ −1 and therefore 0 < β < 1 which completes the demon-
stration that T pi is a contraction.
Then equation (3.2.5) implies that
(T piV )(i) ≤ (T piV˜ )(i) + βψ(i) max
j
∣∣∣V (j)− V˜ (j)∣∣∣
ψ(j)
and taking the maximum over pi on both sides we have :
(T ?V )(i) ≤ (T ?V˜ )(i) + βψ(i) max
j
∣∣∣V (j)− V˜ (j)∣∣∣
ψ(j) .
The same kind of inequality can be obtain interchanging the role of V and V˜ which
completes the demonstration that T ? is a contraction.
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3.2.3 Some more details on our implementation
See Annex 1 (confidential).
3.2.4 A qualitative analysis on one of our tasks
We analyze here the policy obtained by using a look-up table value iteration algorithm
on a small sub-task (it remains 8 relevant symptoms to check) in order to illustrate some
of the dilemmas a medical doctor can face during an examination. We start with the
presence of symptom 9. The three diseases which does have symptom 9 in their list of
typical symptoms are displayed in table 3.1. We should think, for this one experiment only,
that the symptoms are conditionally independent given the disease. Another important
information is the prevalence of each disease, we have P[D = d1] = 0.042, P[D = d2] =
0.0083 and P[D = d3] = 0.0083. Finally there is no relation of ascendant/descendant
between the 9 symptoms considered in this example. The optimal strategy obtained
induces a decision tree which is displayed in Figure 3.3.
Table 3.1 – List of plausible diseases and corresponding list of related symptoms for the
sub-task starting with presence of symptom 9.
Disease 1 Disease 2 Disease 3
Id Symptom Probability Id Symptom Probability Id Symptom Probability
1 0.50 6 0.90 2 0.90
2 0.55 7 0.50 4 0.90
3 0.50 9 0.90 6 0.50
5 0.90 9 0.50
8 0.50
9 0.50
The first question is comprehensible, it ask about the most plausible symptom of
the most plausible disease: the symptom 5. If the answer was positive it continue with
a symptom typical of the first disease which is not also typical of other diseases: the
symptom 3. The combination of the presence of this two symptoms is sufficient to diagnose
the disease 1. The rest of the tree is less obvious. For example when we get a "yes" for
symptom 5 and a "no" for symptom 3, should we continue asking symptoms related to
disease 1 or should we switch to the symptoms typical of the other diseases? The founded
path chooses a symptom related to both disease 1 and disease 3 (symptom 2), probably
because it is then easy (and fast) to discard disease 3 by asking a question about symptom
4 (note that the disease 3 has only 3 related symptoms).
Another interesting parts of the tree is when we received a negative answer to our first
question about the symptom 5. Then, the initial most plausible disease (the disease 1)
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Figure 3.3 – Optimal decision tree for a subtask with 8 possible symptoms.
becomes less likely, but it is not clear if its probability decreases that much that we should
check symptoms of other diseases or not. In this case the optimal strategy is to switch to
symptoms of disease 3 which has less typical symptoms and must be (in this part of the
tree) more plausible than the disease 1.
Due to its size, we do not draw the entire decision tree but only the 6 first symptoms
to check, we wrote ”...” for the leaves where the obtained diagnostic strategy still propose
to check more symptoms.
3.3 A policy-based approach with hand-crafted features as
a baseline:
3.3.1 Classic greedy algorithm to optimize decision trees
The classic greedy algorithm for decision tree optimization consists in choosing at each
node the features which minimize the average entropy of the target Breiman et al. [1984],
Quinlan [1986]. To be more precise we can write it under the form of the following
deterministic strategy, ∀s ∈ S:
piBreiman(s) = arg max
a∈A
H(D | s)− E[H(D | s, a)]
The quantity H(D | s)− E[H(D | s, a)] is sometimes referred as the information gain
as it measures the average loss of uncertainty about the target outcome that produce
action a.
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3.3.2 Energy-based policy mixing several reasonable way to play ©
Stochastic vs deterministic policy We defined in equation (3.1.1) our policy as a
deterministic mapping from state to actions but note that we could also define the policy
as a mapping associating to each state s the probability to take each possible action a:
pi : S× A→ [0, 1]
pi(s, a) thus stands for the probability to take action a when being in state s.
However, as long as the environment P is well known and fixed, the optimal policy pi?
is deterministic.
This is a direct consequence of the Bellman optimality equation (3.2.1). The max
operator induce a deterministic policy which takes at each state the best action, i.e the one
which maximize the value function (for all s ∈ S, and all policy pi we have Vpi?(s) ≥ Vpi(s)).
A stochastic policy can therefore be at best as good as the optimal policy and worst if the
different action possible at a given state does not give the same outcome.
Nevertheless in our application it can be interesting to propose several symptoms to
check at the user,each with its corresponding score (interest to check it), instead of a single
one. Indeed physicians might be reluctant to use a decision support tool which do not
let them a part of freedom in their choice. This is why we will also consider stochastic
policies.
Energy-based policy: We consider here an energy-based formulation, a popular choice
as in Heess et al. [2013]:
piθ(s, a) =
eθ
Tφ(s,a)∑
b e
θTφ(s,b)
where piθ(s, a) is the probability to take action a in state s, φ(s, a) is a feature vector: a
set of measures linked with the interest of taking action a when we are in state s. To be
more precise:
φ(s, a) =
(
H(D | s)− E[H(D | s, a)], P [Sa | s],1Aa∈Smax(s)
)
where Smax(s) is the set of typical symptoms of the most likely disease at state s and
H(D | s) is the entropy of the random variable disease at state s. In words φ(s, a)
summarizes three reasonable way to "play" our game.
• Ask the question that minimizes the expected entropy of the disease random variable.
This is exactly the Breiman et al. [1984] way to play.
• Ask the question where the probability of a positive answer is maximum. It is specific
to our game where positive answers are much more informative than negative answers
(it would not be the case in a classic 20 questions game).
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• Inquire symptoms related to the currently most plausible disease.
These features have been identified as relevant measures in rare disease research by
physicians we are working with. They represent different way to think and dilemmas faced
during medical examination: when I observed a symptom should I think about symptoms
usually observed jointly or should I think about the most plausible disease and look for
the corresponding symptoms?
Note that this parameterized function piθ is nothing more than a neural network with-
out hidden layer designed with hand-crafted features. When properly optimized this policy
outperforms, by construction, classical decision tree algorithm Breiman et al. [1984].
3.3.3 Learning algorithms for policy gradient methods in RL
Our aim is to learn good parameters θ for each of our 220 sub-problems:
θ?(i) = arg min
θ
Li(θ) := Epiθ [I | s(i)].
This kind of optimization problem, has been well studied by the reinforcement learning
community, see Konda [1999] or Sutton et al. [1999] for the general analysis and Heess
et al. [2013] for the energy-based particular case.
Note that we are not able to compute exactly Li(θ) neither its gradient. Let us have
a closer look to L(θ) (we drop the i index in the following):
L(θ) = Epiθ [I | s0] =
∑
a
piθ(s0, a)Qpiθ(s0, a)
Most of the time we use ∇θ log(piθ(s, a)) instead of ∇θpiθ(s, a) as in our case of soft-max
policy ∇θ log(piθ(s, a)) can be written in a very simple way:
∇θ log(piθ(s, a)) = φ(s, a)− Epiθ [φ(s, .)].
and because there is a simple relation between both of them:
∇θpiθ(s, a) = piθ(s, a)∇θpiθ(s, a)
piθ(s, a)
= piθ(s, a)∇θ log(piθ(s, a)).
The policy gradient theorem (see Sutton et al. [1999]) ensure us that:
∇L(θ) = Epiθ [∇θ log(piθ(s, a))Qpiθ(s, a)] .
The algorithm REINFORCE (see Williams [1992] and the pseudo-code 1) use directly
this theorem to derive a gradient-based algorithm, it uses a return vt as an unbiased sample
of Qpiθ(s, a):
∆θt = α∇θ log(piθ(st, at))vt.
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Algorithm 1 REINFORCE algorithm.
Initialization of θ.
while The computational budget has not been exhausted do
Generate a new episode {s1, a1, r2, ..., sI−1, aI−1, rI}
for t=1: I-1 do
θ ← θ − α∇θ log(piθ(st, at))vt
end for
end while
This algorithm suffer from the high variance of the estimate of Qpiθ(s, a). Using a
single sample vt for each gradient descent step generally produces a very unstable learning
progress.
In order to reduce the variance of the update, a traditional solution consist in using a
baseline. Let B be a function only depending on the state s (and not on the action) then
the policy gradient theorem can be rewrite as :
∇L(θ) = Epiθ [∇θ log(piθ(s, a)) (Qpiθ(s, a)−B(s))]
since
Epiθ [∇θ log piθ(s, a)B(s)] =
∑
a
piθ(s, a)∇θ log piθ(s, a)B(s)
=
∑
a
∇θpiθ(s, a)B(s)
= ∇θ
(
B(s)
∑
a
piθ(s, a)
)
= ∇θB(s)
= 0
A classical choice for the baseline is an estimate of the state value function B(s) =
Vw(s). The parameters w can also be learned with a Monte-Carlo algorithm see 2.
Algorithm 2 REINFORCE with Baseline.
Initialization of θ and w.
Initialization of learning rates αw and αθ.
while The computational budget has not been exhausted do
Generate a new episode {s1, a1, r2, ..., sI−1, aI−1, rI}
for t=1: I-1 do
δ ← Gt − Vw(st) where Gt is the return at step t.
w ← w − αwδ∇wVw(st)
θ ← θ − αθδ∇θ log(piθ(st, at))
end for
end while
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3.4 A value-based approach:
3.4.1 Training Deep Neural Networks
We recall that the Q-values are defined as
Qpi(s, a) = E
[ I∑
t′=t
rt′ | st = s, at = a, pi
]
,
namely this is the expecting amount of reward when starting from state s, taking action
a and then following the policy pi. The optimal Q-values, are defined as Q?(s, a) =
maxpi Qpi(s, a) and satisfy the following Bellman equation:
Q?(s, a) = Es′∼P [r + max
a′
Q?(s′, a′)].
The optimal policy pi?, is directly derived from Q?: pi?(s) = arg maxaQ?(s, a). There-
fore we "only" need to evaluate Q?(s, a), ∀s, a. This can be done by a value-iteration
algorithm which uses the Bellman equation as an iterative update:
Qi+1(s, a) = E[r + max
a′
Qi(s′, a′)|s, a].
It is known, see Sutton and Barto [2018], that Qi → Q? when i→∞.
As the dimension of the problem is too high to store/evaluate all the Q-values, we
parameterized it by a neural network: Q(s, a) ≈ Qw(s, a).
The famous Deep Q-Network (DQN) algorithm proposed by Mnih et al. [2013] made
possible the use of neural networks to parameterize the Q-values (then called Q-network)
in the value iteration algorithm with function approximation. The Q-network, at iteration
i, is trained by minimizing the loss function
Li(wi) = Es,a
[(
yi −Qwi(s, a)
)2]
where yi = Es′∼P [r + maxa′ Qwi−1(s′, a′)|s, a] is the target. This can be done by a
standard back-propagation algorithm. In practice to successfully combine deep learning
with reinforcement learning, the main idea is to use experience replay to break correlation
between data: build a batch of experiences (transitions s, a, r, s′) from which one sam-
ples afterwards. Another trick is to freeze the target network during some iterations to
overcome instability while learning.
By doing so acting and learning are dissociated, the policy used to act (called behavior
policy) is different from the one learned from the transitions sampled in replay memory
(the target policy). In RL, this type of algorithm are called off-policy methods. It is a
desirable propriety for a RL algorithm to be off-policy as the behavior policy is designed
to enforce exploration.
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Figure 3.4 – General schema of Deep Reinforcement Learning algorithms.
Figure 3.4 shows the general simplified scheme of the algorithms used in deep reinforce-
ment learning: an agent interact with its environment and collects data (transitions st, at,
rt, st+1) which are incorporated to the replay memory from which we sample to form the
target policy. Periodically the behavior policy is updated with the current learned policy.
In our case we update the behavior policy as soon as we made a gradient ascent step.
3.4.2 Some remarks on the behavior policy
Our behavior policy is an -greedy version of the current learned policy in order to en-
force exploration. We use this policy to simulate games, or more precisely transitions
(st, at, st+1, rt).
For this purpose, we need a model of the environment, a transition model which told
us the probability to reach a state st+1 when taking action at in st. Our environment
model is composed of the symptoms combination distribution of each disease (see chapter
4). Namely we store (P [B1, ..., BKD | D])B1,...,BKD the probability of all the possible
combinations of typical symptoms given the disease,KD is the number of typical symptoms
of D. We add the assumption that a patient can also presents non-typical symptoms but
with small probability and independently of the others symptoms (see section 4.6.2).
Then to simulate transitions we need to determine for each disease which are the symp-
toms of the current list which are typical and which are not. It allows us to find the right
combination we have to extract from (P [B1, ..., BKD | D])B1,...,BKD . This computation is
not that cheap especially when we add ontological considerations (see chapter 5). We can
speed it when we play games from the start s0 to a terminal state sI : we remember which
symptoms are typical for each disease and thus only have to determine if the last symptom
is typical or not.
Note that, at each stage of a game, we have to compute the probability of the symptoms
combination given each disease so as to determine whether we should stop or not. Another
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important observation is that trying to compute directly P[sI | s0] is as costly as playing
an entire game incrementally (as previously described) from s0 to sI .
These two observations should convince the reader that an asynchronous learning ap-
proach, as in Mnih et al. [2016], would not be suitable for our problem. From a computa-
tional perspective, it is reasonable to play games from the start to a terminal state.
3.4.3 The update target: Temporal-difference and Monte-Carlo algo-
rithm
A remaining question concerns the definition of the update target, should we use Monte
Carlo returns or bootstrap with an existing Q-function ?
We recall (following Sutton and Barto [2018]) that an algorithm is a bootstraping
method if it bases its update in part on an existing estimate. This is the case of the
Temporal-Difference (TD) algorithm defined as:
Qk+1(s, a)← (1− α) Qk(s, a)︸ ︷︷ ︸
old estimate
+α
(
r(s, a, s′) + max
a′
Qk(s′, a′)
)
︸ ︷︷ ︸
update
where we sampled s, a, s′ using the current policy (in a -greedy way in order to enforce
exploration) and the environment model P. Qk is the estimate at iteration k, α the
learning rate. On the contrary a Monte-Carlo method does not bootstrap:
Qk+1(s, a)← (1− α)Qk(s, a) + αG
where G is the reward we received from a simulated game.
It is not clear at first sight whether we should use a TD method or a MC method to
compute the target yi. This question is the subject of a recent work Amiranashvili et al.
[2018] which show that MC approaches can be a viable alternative to TD in the modern
reinforcement learning era. Usually TD method is seen as a better alternative than MC
method which is often discarded because of the high variance of the return.
Nevertheless our case study is specific: we face a finite-horizon task with a final reward:
the reward signal is not very informative before reaching a terminal state. In addition,
for the subproblems of intermediate dimensions, we are ensured that games do not last
too much time and then that there is a small variance in the return of the Monte-Carlo
episodes.
We implemented both solutions referred as DQN-TD and DQN-MC. At each step of
DQN-MC, we sample, following the behavior policy, 100 games starting from the initial
state s(i) and stopping when they reach a terminal state. All the transitions s, a, s′ of all
these games are annotated with the reward they received (the number of questions that
have been necessary to reach a terminal state during the game concerned) and incorporated
in the replay memory. We then sample transitions from this replay memory (one twentieth)
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and perform a gradient ascent step with a back-propagation algorithm (we used the Keras
library Chollet et al. [2015]).
Concerning the DQN algorithm with TD method, we kept the main features of DQN-
MC in order to facilitate their comparison. We play 100 games, still with the behavior
policy, and all the transitions s, a, s′ of all these games receive a −1 reward when s′ is
not terminal, 0 otherwise. The learning rate is initialized with a lower value than in the
DQN-MC algorithm but it is decreased in exactly the same way in both cases: divided by
two each 300 iterations. Another difference is the frozen network we use as target in DQN-
TD which is not needed in DQN-MC. We update the frozen network each 2 iterations (we
have also tried to update it less frequently but have not observed any major differences
with the results presented here).
We compared these two algorithms, DQN-MC and DQN-TD, on severals of our sub-
tasks (see figures 3.9 and 3.10). We did not observed much difference on small and in-
termediate sub-problems: both algorithms converge at the same speed towards solutions
of the same quality. Nevertheless DQN-TD appears much more sensitive to the learning
rate. Indeed as it can be seen in Figure 3.9, DQN-TD converge on this problem, where
it remains 29 relevant symptoms to check and 8 possible diseases, when the learning rate
is initialized at 0.0001. Nevertheless if the learning rate is chosen a little bit higher, at
0.001, DQN-TD diverge. On the contrary, DQN-MC converge when the learning rate is
initialized to 0.001 and also when initialized to 0.01 even if the returns of the algorithm
are less stable in this latter case. These observations have to be combined with the one
of Figure 3.10 where it remains 104 relevant symptoms to check and 18 possible diseases.
We can see that in this case DQN-TD with an initial learning rate of 0.0001 diverge.
Reducing the learning rate to 0.00001 does not change this fact. On the contrary we do
not need to reduce the initial learning rate of DQN-MC (we take it equal to 0.001) to
make it converge to a good solution. Since we have to train as many neural networks
as the number of sub-tasks, we need a robust algorithm able to deal with different task
complexity without changing all the hyper-parameters.
This is why we chose to use DQN-MC instead of DQN-TD. It is, indeed, a well-
known issue sometimes referred as "deadly triad" Sutton and Barto [2018] that combining
function approximation, off-policy learning and bootstrap to compute the target (what
the DQN-TD algorithm does) is not safe. We show that DQN-MC performs well on small
and intermediate sub-tasks of our problem. The higher dimensional tasks are harder to
solve because the games are expected to last longer which is a challenge both in term of
computing time that in terms of learning stability (higher variance of the return). To scale
up on such problems, we break down the state space into a partition and leverage already
solved sub-tasks as bootstrapping methods.
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Algorithm 3 DQN-MC with Bootstrapping on already solved sub-tasks.
Start with low dimensional tasks.
for i such that the task Ti has not been yet optimized do
if |Bi| ≤ 30 then
while the budget for the optimization of this task has not been reached do
Play 100 games (-greedy) from the start s(i) to a terminal state.
Integrate all the obtained transitions to the Replay-Memory
Throws part of the Replay-Memory away (the oldest transitions of the replay)
Sample 1/20 of the Replay-Memory
Perform a gradient ascent step (backpropagation algorithm) on the sample
end while
end if
end for
Continue with higher-dimension tasks.
while there are still tasks to be optimized do
Choose the easiest task to optimize: the one with the highest proportion
of already solved sub-tasks (weighted by their probability to be faced)
while the budget for the optimization of this task has not been reached do
Play 100 games (-greedy) from the start s(i) to a terminal state (condition (j))
or to a state that was yet encountered in an already solved task (condition (jj))
if we stopped a game because of condition (jj) then
Bootstrap i.e use the network of the sub-tasks to predict
the average number of question to reach a terminal state
end if
Integrate all the obtained transitions to the Replay-Memory
Throws part of the Replay-Memory away (the oldest transitions of the replay)
Sample 1/20 of the Replay-Memory
Perform a gradient ascent step (backpropagation algorithm)
end while
end while
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3.4.4 Solving higher dimension tasks by bootstrapping with already
solved sub-tasks ©
We denote Bi = (Bi1 , ..., Bik) the set of symptoms related with the symptom i, i.e this
is the set of symptoms which are still relevant to check after observing the presence of
symptom i. When |Bi| is small enough (say |Bi| < 11), we can learn the optimal policy
pi? by a simple Q-learning lookup table algorithm, see Sutton and Barto [2018].
Considering intermediate dimension problems (say 11 < |Bi| < 31) we can use the
DQN-MC algorithm which performs pretty well on these problems (see experiences in
section 3.5.2). For high-dimensional problems (|Bi| > 30) using directly the DQN algo-
rithm would be time-consuming. An easy way to accelerate the learning phase of these
big networks is to make use of the smaller networks previously trained. Indeed if Si is a
symptom for which |Bi| is high, there must have some Sj ∈ Bi such as |Bj | is small enough
and therefore such as the Q-values of pi?(j) have been yet computed or at least approached.
Put in another way, when we try to learn the optimal Q-network of a given problem, we
yet know, for some inputs, the Q-values that should output a quasi-optimal Q-network.
There are several ways to take advantage of these already optimized subtasks to opti-
mize networks on larger tasks. A first idea would be to incorporate to the replay-memory
of the larger task, the replay-memories of the already solved sub-tasks by having previously
properly resized the states. Remind that at each iteration, i.e each gradient ascent step,
we sample transitions from the replay-memory (s, a, s′ and the reward received at the
end of the game R) to form the target and train set used to perform the back-propagation
algorithm step. We can add to these sets some immovable transitions, the one we already
know (because they appear in sub-problems already solved).
However, by doing so we will face several issues. First, when we train our neural
network using the replay memory constituted by playing on the concerned task, we are
ensured that the transitions that populate our replay-memory will be present in a pro-
portion equivalent to their probability of being encountered in the task. On the contrary,
when we add some immovable transitions from already solved sub-tasks to our replay
memory, we might over-optimize our network on these sub-tasks. Put it another way, the
network will be over-optimized on parts of the decision tree which are not that frequently
faced in practice.
Secondly, although the length of the episodes will have been reduced since using the
subtasks replay-memories allows us to learn more quickly how to play at the end of the
games, it will still be time consuming to play from the beginning until the end of the
episodes for tasks of high dimension. The length of the episodes will also be an issue
considering the variance of the MC returns.
Therefore a second idea would be to learn a policy on the higher dimension task by
bootstrapping on already solved subtasks. Namely we play games starting from the initial
state s(i) and bootstrap when reaching a state that belongs to a state set of the partition
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where there yet exist an optimized network. In practice we have a function which is called
each time we received a positive answer which checks if there already exists a network
optimized for such a starting symptom. If this is indeed the case, the current game is
stopped and the corresponding optimized network is called to predict the average number
of question to ask to reach a terminal state. The main lines of the whole procedure are
summarized in the algorithm 3
Note that in doing so, we do not optimize the network for the entire task. It is
therefore necessary to change the neural network used for the recommendation during the
examination when we change the space of the partition. The advantage is that we do not
need to use a more complex architecture for this higher dimension task.
3.4.5 Some remarks on the complexity of a task
When we described the several tasks Ti, we focused mainly on the number of remaining
relevant symptoms to check denoted |Bi|. This is the most important parameter since it is
the input length of our network and then determines the number of network parameters
that we have to optimize.
Nevertheless there are more parameters which influence the complexity of a task. Let
us mention the number of possible diseases and especially their probabilities. Indeed,
if there are many possible symptoms to check and many possible diseases but there is
a disease that is much more plausible than the others, then the task is not so difficult.
Another feature that can influence a task complexity is the amount of symptoms which
are typical of several of the possible diseases.
Thus as it seems difficult to quantify the difficulty of a task we should avoid to judge
the performance of our algorithms in an absolute way but should always compare them
to more classical methods.
Finally note that even what we call "task complexity" is not that easy to define. An
idea would be to define the complexity of a task as the difference between the average
number of question that have to ask a random policy and the average number of question
that have to ask the optimal policy.
3.4.6 Considerations on the possibilities of parallelizing computations
One of the other advantage of fragmenting the general task as several sub-tasks more
easily optimizable is the possibility to optimize the different sub-tasks in parallel.
As we have seen yet the different sub-tasks (Ti)220i=1 are connected. When we observe
the presence of a symptom Bi, there is a whole set of abnormalities Bi that can be related
to this abnormality because they are typical of disease for which symptom Bi is typical.
We display in the graphs of figures 3.5 and 3.6 the links between the different sub-tasks
for our database. Each node of the graph represents a task, i.e an initial symptom from
which we start the medical examination. The links between the nodes are all the darker
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as the probability of observing both symptoms together is high. Note that there no reason
that P[Bi | Bj ] = P[Bj | Bi] for i 6= j this is why the thickness of a link between node Bi
and node Bj is computed by the following formula:
1
2 (P[Bi | Bj ] + P[Bj | Bi])
There is no links between two nodes when the two corresponding symptoms are not
associated to any common disease in the database. In the figure 3.6 the only difference in
comparison with figure 3.5 is the fact that we removed, for visual reasons, the symptoms
that were connected to less than 8 symptoms (the Bi for which |Bi| ≤ 8).
The graph obtained appears deeply connected, only a few symptoms are totally dis-
connected from the others.
An interesting question would be to determine how to allocate the computational
resources among the remaining tasks to optimize so as to minimize the computation time
required.
It nevertheless seems hard to face this problem with more than a heuristic : to choose
at each step to optimize the Q-networks which has the highest rate of sub-problems already
solved (where each sub-tasks is weighted by its probability to be faced).
3.5 Numerical Results
For all the experiments involving neural networks, we used the same architecture detailed
in table 3.2. We first use an embedding layer since the inputs processed by our neural
network should not be treated as numerical values. We then use two hidden layer with
ReLu activation and a final layer with linear activation which outputs the Q-values of
the possible actions. The  parameter of our stopping criterion is set to 10−6 for all the
experiments.
Table 3.2 – Neural network architecture for task Ti. |Bi| the number of remaining relevant
symptoms to check.
Name Type Input Size Output Size
L1 Embedding Layer |Bi| 3× |Bi|
L2 ReLu 3× |Bi| 2× |Bi|
L3 ReLu 2× |Bi| |Bi|
L4 Linear |Bi| |Bi|
3.5.1 Our baseline has quasi-optimal performances on small subprob-
lems ©
We can compare the performance of our policies optimized by a REINFORCE algorithm
(the ones of section 3.3), with a policy derived from the classic decision tree algorithm that
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Figure 3.5 – Graph of the links between the sub-tasks.
we call Breiman policy: choosing the action that minimize the target entropy at horizon 1
(see Breiman et al. [1984]). We also compare these policies with the true optimal policies
when it was possible to compute the latter, i.e. when the dimension was small enough.
Results on some of our subtasks are presented in Figure 3.7. Our energy-based policy
appears to clearly outperform a classic Breiman algorithm and all the more so as the
dimension increases: the average number of questions to ask may be divided by two in
some cases. On small subproblems where we have been able to compute the optimal policy
by a dynamic programing algorithm, our energy-based policy appears to be very close to
the optimal policy.
3.5.2 DQN-MC algorithm vs our baseline ©
We have performed a DQN-MC algorithm on our subtasks. We expect this algorithm
to find a better path than the energy-based policy of section 3.3 since a neural network
has many more parameters and can therefore handle many more different situations than
our baseline. Nevertheless to train such a high dimensional function instead of the three
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Figure 3.6 – Graph of the links between the sub-tasks.
parameters of our baseline has a cost. How much iterations does need a DQN-MC to
outperform our baseline?
We recall here that an iteration of the DQN-MC algorithm consist in playing 100
games that are added to the replay memory, then we sample one twentieth of this replay
memory and perform a back-propagation algorithm. For comparison, our baseline has been
trained with a REINFORCE algorithm, each iteration consist in playing one game and
performing a gradient ascent step accordingly, we stop the training phase when reaching
1000 iterations.
Figures 3.11 and 3.12 show, as expected, that the DQN-MC algorithm needs more
simulations of games than our baseline. Indeed in these two sub-tasks, DQN-MC needed
respectively 40 and 200 iterations to reach our baseline, so 40×100 = 4000 and 200×100 =
20000 games instead of the 1000 which trained our baseline. In Figure 3.11, for a sub-task
of dimension 10, we can see that the DQN-MC algorithm needs a reasonable amounts of
games to outperform our baseline. In that case, the DQN algorithm found a very good
diagnostic policy but did not reach the optimal policy, it is probably stuck in a local
extrema (although we do use an exploration parameter).
In Figure 3.12, the DQN algorithm seems to converge toward the baseline. This might
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Figure 3.7 – Average number of questions
to ask on several subtasks. Figure 3.8 – Dimensions of the different
sub-tasks.
Figure 3.9 – Comparison of DQN-TD and DQN-MC. Task dimension: 29.
be due to the fact that, in these tasks of intermediate dimension (it remains 26 relevant
symptoms and 8 diseases), our baseline is yet a good solution close to the optimal policy.
Thus the DQN algorithm which is not ensured to converge to the optimal policy might
get stuck in a local extrema at the level of the baseline.
These experiments can be conducted in a laptop without use of GPU and should be
then easily reproducible using our environment simulator or a similar one.
Finally, as one might expect considering the difference of needed iterations to converge
between Figure 3.11 and Figure 3.12, the idea of using previously resolved subtasks will
be important to deal with high-dimensional tasks.
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Figure 3.10 – Comparison of DQN-TD, DQN-MC and DQN-MC-Bootstrap. Task dimen-
sion: 104.
3.5.3 Bootstraping on already solved sub-tasks helps (a lot) for high-
dimensional tasks ©
In these experiments, we compare the performance of a simple DQN-MC algorithm against
a DQN-MC-Bootstrap on some of our tasks. We used the same neural network architecture
for both algorithms (see table 3.2). The two algorithms use exactly the same hyper-
parameters, the only difference being the bootstrap trick of DQN-MC-Bootstrap.
Figures 3.13 and 3.10 show the benefits of using the solved sub-tasks as bootstraping
methods. In both cases a simple DQN-MC is unable to find a good solution while a DQN-
MC-Bootstrap outperforms pretty quickly our baseline. Note that the neural network
trained with DQN-MC-Bootstrap starts with a policy that is not that bad. It is appreciable
as it reduces, since the beginning of the training phase, the length of the episodes and
then the computing cost associated.
For the experiment of Figure 3.13 it remains 70 relevant symptoms to check, 9 possible
diseases including the disease "other", and 20 sub-tasks have been already solved. Finally
the probabilities of presence of each of the subtasks initial symptom given the initial
symptom of the main task were (0.01; 0.44; 0.01; 0.15; 0.15; 0.01; 0.03; 0.02; 0.11; 0.01;
0.26; 0.01; 0.03; 0.01; 0.15; 0.01; 0.15; 0.24; 0.16; 0.06).
For the experiment of Figure 3.10 it remains 104 relevant symptoms to check, 18
possible diseases including the disease "other", and 103 sub-tasks have been already solved.
Finally we have been able to learn a good policy for the main task (3.1.2) where
it remains 220 relevant symptoms to check, 82 possible diseases including the disease
"other" and all the possible sub-tasks have been already solved. Our DQN-MC-Bootstrap
algorithm starts with a good policy which only needs 45 questions on average to reach a
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Figure 3.11 – Evolution of the performance of the neural network during the training phase
with DQN-MC. Task dimension: 10.
Figure 3.12 – Evolution of the performance of the neural network during the training phase
with DQN-MC. Task dimension: 26.
terminal state. Some training iterations allows it to improve until needing 40 questions to
reach a terminal state. On the contrary the experiment we made on a DQN-MC which tries
to solve from scratch this task has to ask 117 questions, on average, to reach a terminal
state and does not improve significantly during the 1000 iterations. We have evaluated
also the performance of the Breiman policy on the global task, it needs 89 questions on
average to reach a terminal states (with a variance of 10 questions).
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Figure 3.13 – Evolution of the performance of the neural network during the training
phase. Task dimension: 70.
3.6 Theoretical and empirical analysis of some difficulties
linked to the partitioning of the state space
3.6.1 Partitioned MDP in the look-up table case
Let us assume to simplify the analysis, and without loss of generality, that we split the
state space S into a partition of two sub-spaces S1 and S2 : S = S1 unionsq S2.
We assume that we always start from state s0 ∈ S1 and that all the descendant of the
states of S2 belong to S2. Namely when we play a game we start in S1 and when we reach
a state of space S2 we stay in this part of the state partition until the end of the game (we
can not move back to S1).
We aim to learn a strategy pi? = arg maxpi E[R | s0, pi] and for that aim to solve the
two following optimization problems on each element of the partition :
pi?1 = arg max
pi:S1→A
E[R | s0, pi]
pi?2 = arg max
pi:S2→A
E[R | F(S1,S2), pi]
where F(S1,S2) is the set of states at the frontier between S1 and S2, more precisely
this is the set of states of S2 that can be reached from S1 by taking an unique action. To be
exact in the definition of pi?2 we could think that it is necessary to precise the distribution
on the initial state F(S1, S2). In fact note that as long as all the elements s˜ ∈ F(S1, S2)
have a positive probability to be chosen as initial state, the policy pi?2 remains the same.
This is a direct consequence of the Bellman principal of optimality.
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Moreover let us denote by p˜i the aggregation of pi?1 and pi?2, i.e p˜i(s) = pi?1(s) if s ∈ S1
and p˜i(s) = pi?2(s) if s ∈ S2. Then we have that pi? = p˜i.
In other words we can learn independently the policy on S1 and the policy on S2 when
we aim to learn pi?.
3.6.2 Partitioned MDP and parameterization of the policy
Things are starting to get more complicated when we use a parameterization of the policy.
This is due to the fact that the optimal parameterized value function does not verify the
Bellman optimality equation. Intuitively the fact that we presented in the last section
that the policy pi?2 remains the same whatever is the distribution put on the initial states
set F(S1, S2) is no longer verified when we use a parameterized policy piθ?2 .
Let us denote V (j)pi (s) the amount of reward collected by the policy pi on the space Sj
starting from the state s.
We denote
piθ?1 = arg max
piθ∈Πθ,piθ:S1→A
E[R | s0, pi]
and
piθ?2 = arg max
piθ∈Πθ,piθ:S2→A
E[R | Fpiθ?1 (S1, S2), pi]
where Fpiθ?1 (S1, S2) stands for the set of states at the frontier between S1 and S2 where
each state s of this set has a probability ppiθ?1 (s | s0) to be the initial state.
We can thus write, for s ∈ S1 :
Vpi?(s)− Vpiθ? (s) = V (1)pi?1 (s) +
∑
sT
ppi
?
1 (sT | s)V (2)pi?2 (sT )
−
(
V
(1)
pi?
θ1
(s) +
∑
sT
p
pi?θ1 (sT | s)V (2)pi?
θ2
(sT )
)
= ∆pi?,piθ?1V
(1)(s) +
∑
sT
p
piθ?1 (sT | s)∆pi?,piθ?2V
(2)(sT )
+
∑
sT
(
ppi
?
1 (sT | s)− ppiθ?1 (sT | s)
)
V
(2)
pi?2
(sT )
The last equality is composed of three terms. Two of them only depend on the fact
that there is no reason why pi? would belong to Πθ, this is the sense of ∆pi?,piθ?1V
(1)(sT )
and ∆pi?,piθ?2V
(2)(sT ).
The third term of this equality expresses the idea that the discrepancy of the states
reached at the frontier following piθ?1 instead of pi
?
1 has a negative impact on the quality of
the solution found: piθ? .
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3.6.3 Experiment on a subtask
We have evaluated the difference Vpi?(s)− Vpiθ? (s) on a particular sub-task where we were
able to learn the optimal policy pi? using the value iteration algorithm.
In the sub-task chosen it remains 12 relevant symptoms to check and 4 suspected
diseases, including the disease "other". We have approximated piθ? by training a neural
network with a DQN-MC algorithm, see algorithm 3, starting from the state with the
presence of the call symptom in question and no other information on the other symptoms,
let us denote such a state as s0 in this section. The computational budget is fixed to 500
iterations. We denote piθ˜ the obtained policy.
We computed the difference Vpi?(s) − Vpiθ˜(s) for all the states s where we add all the
possible combinations of 0 to s0. There are thus 212 = 4096 possible states.
Each Vpiθ˜(s) is estimated by simulating 1000 games starting from state s until the end
of the game and we took the average result.
We have obtained Vpi?(s0)−Vpiθ˜(s0) = 0.15 where Vpi?(s0) = 2.44 so the obtained policy
is pretty closed to the performance of the optimal policy when starting from s0.
We can see in figure 3.14 that most of the time the fact to have trained the neural
network by starting the game in s0 does not have a too bad influence on the performance
of piθ˜ compared to pi?. In the majority of cases we have to ask less than one additional
question comparing with the optimal policy.
Nevertheless this difference can be quite high enough in several cases with up to 4
additional questions. As we are not sure to exactly start in practice from the state s0 we
should try to find solutions to such an issue.
3.6.4 Possible solutions
The discrepancy between the performance of the optimal policy and the performance of
the optimal parameterized policy observed in figure 3.14 could be attributed to various
factors.
A first hypothesis would be to blame the parameterization itself, i.e to consider that
Πθ is not rich enough to cope with the different situations and a solution would be to use
deeper neural network.
Another reason, more plausible, would be that the solution obtained piθ˜ remains far
from the performance of piθ? especially for the states which are very unlikely to be reached
from s0. Indeed we learn piθ˜ by generating games starting from s0 because our goal is to
maximise the amount of reward collected from s0 but if we want to be more efficient on less
visited part of the tree we will have to balanced differently the exploration/exploitation
dilemma.
We recall that so far we tackled the exploration issue by using an exploration factor
for the behavior policy, i.e we choose with probability 0.1 a random action instead of the
current best action. One could think that the solution is to start with a higher exploration
82 Chapter 3. Planning Task
Figure 3.14 – Difference between the value of the optimal policy and the optimal param-
eterized policy on a particular subtask for several states.
factor and to progressively decrease it. Nevertheless we did not observe any significant
improvement in this case.
Another idea consist in training p˜i using a DQN-MC algorithm with a random start
state. We displayed the results in figure 3.16 where all the states has the same probability
to be chosen as the start of a new episode when we simulate games.
We can see that the difference Vpi?(s) − Vpiθ? (s) appears much lower in this case, see
also the boxplot of figure 3.17. Such a more exploratory learning does not have a too
bad influence on the overall quality of the solution found in this particularly case, we got:
Vpi?(s0)− Vpiθ? (s0) = 0.14 instead of 0.15 in the less exploratory case.
It then confirms that the exploration/exploitation dilemna is indeed the heart of the
matter. Moreover the states s where the difference Vpi?(s) − Vpiθ˜(s) is the highest in the
figure 3.14 were quite predictable. These are the states where we add the absence of
symptoms typical of the most plausible disease. Indeed the policy piθ˜ will have done
little to explore this parts of the tree since they are relatively unlikely to be reached when
starting from s0. The figure 3.15 shows that the states where the difference Vpi?(s)−Vpiθ˜(s)
is the highest are the states which have been relatively under-visited during the training
phase. The probability of reaching each state is calculated as the frequency of such a state
in the replay memory divided by the length of the replay memory..
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Figure 3.15 – Difference between the value of the optimal policy and the optimal param-
eterized policy on a particular subtask for several states. Strategy learned with random
start.
This is a well known issue in games where Monte-Carlo Tree Search (MCTS) algorithms
are designed to face such an exploration/exploitation dilemna, see Browne et al. [2012]
for an overview of this field. The standard algorithm used in MCTS is Upper Confidence
Tree (UCT) which is inspired of the Upper Confidence Bound (UCB) bandits algorithms,
see Kocsis and Szepesvári [2006].
Several amelioration have been proposed since such as Rapid Value Evaluation (RAVE)
Gelly and Silver [2007] Gelly and Silver [2011]. A generalization of RAVE (GRAVE) has
been developed by Cazenave [2015]. The main idea is to use the statistics of frequently
visited states to estimate the values of less visited states.
Indeed the deeper we go in the tree, the less simulations each node receives and the
more uncertain our estimates of the values are. The idea of GRAVE is that there is a
trade-off between the accuracy of an estimate and compliance with the current state of
the estimate. To estimate the value of a state that had been visited only a few number of
times (less than a predetermined threshold) Cazenave [2015] use the statistics of a reference
state which is the closest ancestor state that has more playouts than the predetermined
threshold.
Note that in our case, we have a natural measure of the discrepancy between two
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Figure 3.16 – Difference between the value of the optimal policy and the optimal param-
eterized policy on a particular subtask for several states. Strategy learned with random
start.
different states : the Hamming distance. One could then imagine to use not only the
statistics of the closest ancestor but the statistics of all the others states that would be
weighted in function of their distance. One would then biased the estimate of less visited
states by adding a kernel structure. This idea has been studied several years ago for
example in Srinivasan et al. [2015] and exhibited good empirical results. More recently
Xiao et al. [2018] show that this idea of utilizing information of similar states with a kernel
based estimation improves the performance of MCTS in both theory and practice.
3.6.5 Related works
There are many works which aims to find a systematic way to decompose the state space
associated to a dynamic programming problem into a family of smaller DP problems
that can be independently solved and which together would allow to solve the higher
dimensional problem. Let us cite the work of Tsakiris and Tarraf [2012], Tsakiris and
Tarraf [2014] for example. Nevertheless such works have to make too strong assumptions
about the state transition dynamic. They assume that the state transition dynamic is
linear which is the case of a deterministic shortest path but not for a stochastic shortest
path as ours.
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Figure 3.17 – Difference between the value of the optimal policy and the optimal set policy
on a particular subtask for several states according to the different way of simulating games.
This notion of partitioned MDP, also referred as decomposed MDP, has also been
studied in Dean and Lin [1995] where the authors investigate this "divide and conquer"
approach for dimensionality reduction purposes in MDP resolutions. They proposed an
"iterative approximation approach" which learn a policy for each sub-task with a given
law on the frontier states, glue these local policies in a global policy and thus obtain a
new law of the frontier states and iterate this procedure until convergence. However this
algorithm is interesting only if the number of states at the frontiers is limited.
This is why several works as Parr [1998], Laroche [2001] or Lozenguez et al. [2012]
focused on the particular case of "weakly" coupled MDP, where the number of states
connecting two communicating subproblems is assumed to be small.
Nevertheless in our case it does not seem to exist an easy way to decompose the
global MDP in several weakly coupled sub-MDP. This is why we proposed to focus on the
exploration/exploitation dilemna which reduces the bias induced by the fact that we have
an uncertainty about the states in which we start the subtasks.
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3.7 Conclusion
In this chapter we have proposed an original formulation of the sequential decision making
problem associated to the objective of building a symptom checker for the diagnostic of
rare diseases. We have taken into account the need in medicine to reach a high level of
certainty when making a diagnosis. Our aim is to minimize the average number of medical
tests to be performed before reaching this level of certainty.
We have studied several reinforcement learning algorithms and made them operational
in our very high dimensional environment. To do this, we have divided the initial task into
several subtasks and learned a strategy for each subtask. We have proven that appropriate
use of intersections between subtasks can significantly accelerate the learning process. The
strategies learned have proven to be much better than classic greedy strategies.
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Chapter 4
Learning a model of the
environment
Abstract: In this chapter we study the problem of building a model of
the environment on which our algorithms will be trained. It is a crucial
aspect for many applications, since it is often impossible to deploy in
real life an algorithm that has not yet been optimized due to the costs
generated by bad decisions. In our case we start without any clinical
data and therefore have to rely on expert knowledge entirely. However,
we plan to collect empirical data as the decision support tool is used. We
present here two main ways to combine the initial experts knowledge, ex-
pressed as conditional probabilities, with clinical data: a penalized max-
imum likelihood approach and a second one consisting in a barycenter
between experts and data. We are particularly interested in the interme-
diate regime where we do not have enough data to do without our initial
a priori, but enough to correct it if necessary. We show, empirically and
theoretically, that our barycenter estimator is always more efficient than
the best of the two models (expert or data) within a constant.
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4.1 Introduction
4.1.1 The need to learn a model of the environment
As described in chapter 3 our agent will be trained by interacting with its environment.
The transitions (initial state, action, reached state, reward)= (st, at, st+1, rt) used to im-
prove the diagnostic strategy can be obtained by interacting directly with the environment
in the real world or by simulation using an approximate model of the environment. These
two different possible approaches are known as:
• Model-based RL: We first build a model of the environment in order to know
how our environment will react to our actions. Then our agent is trained using
experiences simulated from this model (planning task).
• Model-free RL: We do not try to infer the environment dynamic, we just train our
agent using trial-and-error directly obtained by the interaction with the environment.
In our problem, as in most cases of practical applications of reinforcement learning,
a model-free approach is not an option. Indeed, it is often impossible in a medical or
industrial context to deploy in real life an algorithm that has not yet been optimized due
to the costs generated by bad decisions. A model-free architecture would need a very
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large amount of data/time to learn a good policy especially considering the diversity of
situations it will face. This is a time that domain knowledge can save us.
Note that in a number of popular applications of reinforcement learning such an model
of the environment is not necessary. This is the case in recent advances of computer
Go Silver et al. [2017] which shows that it is possible to achieve a superhuman level in
a challenging domain as Go without any domain knowledge, using only reinforcement
learning with self-play. However, we are not in an adversarial game where we could learn
from self play. Another approach is to use expert demonstrations in order to estimate both
rewards and environment dynamics Herman et al. [2016] or to learn directly a policy Tossou
and Dimitrakakis [2013]. Expert demonstrations are often integrated as a supervised
learning initialization step in the AI architecture as in Silver et al. [2016]. We do not have
such expert demonstrations and in any case, since we are interested in rare diseases, we
would need a very large amount of demonstrations to learn a good policy.
Generally speaking our application area is specific by its lack of data, making the
environment dynamic very uncertain. This prevent us from designing our architecture
without any domain knowledge.
We detail in this chapter the model learning phase of our architecture (see figure 4.1)
where we integrate expert data to the data collected by the experience of the algorithm
in order to build a sufficiently accurate model of the environment.
4.1.2 The problem and some notations
Let us denote :
p? = (p?1, ..., p?K) =

P[B¯1, ..., B¯J−1, B¯J | D]
P[B¯1, ..., B¯J−1, BJ | D]
...
P[B1, ..., BJ−1, BJ | D]
 (4.1.1)
the distribution we aim to estimate. In our specific case, we focus on a particular
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disease D and try to estimate the probabilities of the different combinations of symptoms
typical of the disease in question, given the event that the disease of the patient is D.
Let B1,..., BJ be the typical symptoms of the disease D. We aim to estimate the
2J = K different combinations (as P[B1, ..., BL | D] for example) when we only have data
on the marginals P[Bi | D], for all i ∈ [1, J ].
Of course a first idea would be to assume that the symptoms are conditionally indepen-
dent given the disease. However, we expect complex correlations between the symptoms
typicals of a given disease. Indeed we can imagine two symptoms very plausible individu-
ally but which rarely occur together (or even never in the case of incompatible symptoms
such as microcephaly and macrocephaly).
Note that the assumption of conditional independence would make it possible to present
a disease without having any of the symptoms related to this disease in the database (when
there is no Bi such that P[Bi | D] = 1), which should be impossible.
We also have empirical data collected as the decision support tool is used. We denote
x(1),..., x(n) an i.i.d sample from p?.
Generally speaking if we had enough empirical data, we would no longer need the
experts. Conversely, without empirical data, our model must be based entirely on experts.
We detail here the ideas of the two main approaches investigated in this thesis to deal
with intermediate regime where we do not have enough data to do without the a priori
given by the experts but where we have enough data to correct and specify this initial a
priori.
We first recall in section 4.2.1 the principle of maximum entropy which is a common
denominator to our two different approaches. We then briefly introduce the ideas of both
approaches: the maximum-likelihood with entropic penalization in section 4.2.2 and the
barycenter between expert and data in section 4.2.3. We make in section 4.3 a review
of the literature. In section 4.4 we present some experiments which confirm that the
penalized formulation is very sensitive to the choice of the penalization parameter. On
the contrary our barycenter estimator has the advantage to propose an objective way to
choose the weight to be given to experts compared to data. We finally show in section 4.5,
both empirically and theoretically, that our barycenter estimator is always more efficient
than the best of the two models (expert or data) within a constant.
4.2 Mixing expert and empirical data
4.2.1 A common denominator: the maximum entropy principle
The aim to benefit simultaneously from expert data and empirical data has of course a
very old history. This is the very essence of Bayesian statistics Gelman et al. [2004] which
aims to integrate expert data, in the form of an a priori, which is updated with empirical
data using the Bayes’ theorem to obtain what will be called the posterior.
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Note that in our case we do not have a classical a priori modeling the model parameters
with probability distributions. We have an a priori on the marginals as such as a number
of constraints on the distribution to be estimated. The absence of an obvious a priori
to model the distribution of the parameters naturally leads us to the idea of maximum
entropy theorized by Jaynes [1957]. Indeed, if no model seems more plausible to us than
another, then we will choose the least informative. This is a generalization of the principle
of indifference often attributed to Laplace:
"We consider two events as equally probable, when we see no reason that makes one
more probable than the other, because, even if there is an unequal possibility between
them, since we don’t know which is the biggest, this uncertainty makes us look at one as
as likely as the other" de Laplace [1774].
This principle therefore takes the form of an axiom allowing us to construct a method
to choose an a priori: the least informative possible consistent with what we know.
We then define the distribution of maximum entropy as follow:
pmaxent = arg max
p/p∈C˜
H(p) (4.2.1)
where C˜ = C⋂ Cexpert. C = {p/∑i pi = 1, pi ≥ 0} is the probability simplex and Cexpert
is the set of constraints fixed by experts.
Note that pmaxent is well-defined, namely it exists and is unique, as long as Cexpert is a
convex set. Indeed the function p 7→ H(p) is strictly concave and it is well-known that a
strictly concave function under convex constraints admit an unique maximum.
If Cexpert only contained the constraints for the marginals then pmaxent is nothing more
that the independent distribution:
Proposition 4.2.1 Let pmaxent defined by (4.2.1) such that Cexpert is only composed of
the constraints on the marginals P[B1 | D],..., P[BJ | D] then pmaxent is the independent
distribution.
Proof Without loss of generality we can drop the conditioning on the event that the
patient has the disease D. Our proposition is then a direct consequence of the following
classical inequality for the mutual entropy:
H(B1, ..., BJ) ≤ H(B1) + ...+H(BJ) (4.2.2)
with equality if and only if the (Bi)Ji=1 are mutually independent.
As the marginals are fixed, so are the H(Bi) for all i. Then H(B1, ..., BJ) reach its
maximum when the (Bi)Ji=1 are mutually independent and is then equal to H(B1) + ...+
H(BJ).
98 Chapter 4. Learning a model of the environment
Note that the inequality (4.2.2) is a consequence of the chain rule for entropy :
H(B1, ..., BJ) = H(BJ | B1, ..., BJ−1) +H(BJ−1 | B1, ..., BJ−2) + ...+H(B1)
and of the fact that for two r.v X and Y : H(X | Y ) ≤ H(X) with equality if and only if
Y |= X
However, in our case, we can add some information about the structure of the desired
distribution as constraints integrated to Cexpert. We judge impossible to have a disease
without having at least a certain amount of its associated symptoms: one, two or more
depending on the disease. Indeed the disease we are interested in manifest themselves
in combination of symptoms. The combinations allowing the fact to have simultaneously
two exclusive symptoms should also be constraints to be equal to 0. All combinations of
constraints are conceivable as long as C˜ remains a convex closed space, in order to ensure
the existence and uniqueness of pmaxent.
We therefore construct our a priori by taking the maximum entropy distribution check-
ing the constraints imposed by the experts. Thus among the infinite distributions that
verify the constraints imposed by the experts, we choose the least informative distribution
pmaxent, in other words the one closest to the conditional independence distribution.
We need to add information to move from the information provided by the experts
to the final distribution and we want to add as little as possible on what we don’t know.
This approach is referred to as maxent (maximum entropy) and has been widely studied
in the literature Jaynes [1957], Cover and Thomas [2006], Berger et al. [1996].
4.2.2 Maximum likelihood with entropic penalization ©
The idea here is to integrate the collected empirical data by choosing the estimator which
maximize the log-likelihood. However as we do not expect to have sufficient amount of
data to infer the symptoms distributions we regularize this maximum likelihood approach
by an entropic term and by the fact to respect the initial a priori given by experts.
Let us denote
P =

P[B1 | D]
...
P[BJ | D]
P[B¯1, ..., B¯J | D]
...
P[B1, ..., BJ | D]

=:

P[B1 | D]
...
P[BJ | D]
p1
...
pK

(4.2.3)
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and p = (p1, ..., pK). Then our estimator is defined as :
Pnew = arg max
P/P∈C
L
(
x(1), ..., x(n) | p
)
(4.2.4)
+ 
(
H(p)−
∑
i
λiKL (vi||wi)
)
=: arg max
P/P∈C
F(P)
where vi ∼ Be
(
Pexpert[Bi | D]
)
and wi ∼ Be (P[Bi | D]) for all i ∈ [1, J ]. The con-
straint P ∈ C just states the classical probability measure constraints: respect of marginals
and sum equal to one, we also add the constraint to set to 0 symptoms combinations con-
sidered impossible. Note here that we remove the constraints on the marginal experts and
integrate it as a penalization with the Kullback-Leibler term. We have three terms:
• A log-likelihood term for empirical data: L
(
x(1), ..., x(n) | p
)
where x(i) is the i-th
combination of symptoms observed in real life. We aim at maximizing this quantity
since we want our model to be coherent which what we observed. Symptoms com-
binations observed in real life should be considered a little bit more plausible. Note
that the log-likelihood of independent observations x = (x(1), ..., x(n)) under model
P has a very simple form:
L
(
x(1), ..., x(n) | p
)
=
K∑
i=1
Ni log(pi)
whereNj(x) =
∑
k
1{x(k)=j} is the number of times we had observed the j-th symptom
combination.
• An entropic term, H(p), in order not to consider impossible a symptom combination
that has not been yet observed in real life.
• The last term ensures that the marginals of our new distribution will not stray too
far from our initial a priori given by expert data: Pexpert[Bi | D]. We recall that
KL(P ||Q) ≥ 0, ∀P,Q and KL(P ||Q) = 0 ⇔ P = Q Note that each marginal does
not have the same coefficient λi as we do not have the same confidence in all the
expert data. In particular we can handle missing data, i.e when we do not know
P[Bi | D], by setting λi = 0.
As we should see in section 4.4 the main issue of such a penalized formulation is the
choice of the regularization parameter .
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4.2.3 Barycenters between experts and data ©
Recall that p? = (p?1, ..., p?K) and that x(1),..., x(n) is an i.i.d sample of p?. The empirical
distribution pempn = (p
emp
n,i )Ki=1 is given by:
pempn,i =
1
n
n∑
j=1
1{x(j)=i}. (4.2.5)
Following the ideas of section 4.2.1 we define the expert distribution as the distribution
which maximize entropy while satisfying the constraints fixed by experts :
pexpert = arg max
p/p∈C˜
H(p) (4.2.6)
where C˜ is the intersection of the simplex probabilities with the set of constraints fixed
by experts: in our case it is composed of a list of censured combinations and a list of
marginals given by experts. Note that it is possible to give more or less credit to the
marginals given by experts by formulating the constraint as an interval (more or less
wide) rather than a strict equality. The distribution of expert is then defined as the least
informative distribution consistent with what we know.
Let L be any dissimilarity measure between two probability distributions. Our barycen-
ter estimator mixing expert and empirical data is then defined as:
pˆLn = arg min
p∈C/L(pempn ,p)≤n
L(pexpert, p) (4.2.7)
where
n := δn = arg min
l
P[L(pempn , p?) ≤ l] ≥ 1− δ. (4.2.8)
pˆLn is then defined as the closest distribution from experts, in the sense of the dissimi-
larity measure L, which is consistant with the observed data.
For such a construction to be possible, we will therefore have to choose a measure of
dissimilarity L such that we have a concentration of the empirical distribution around the
true distribution for L.
Such a formulation have several advantages over the first approach. First, we do not
have to choose a regularization parameter  which seems to have a strong impact on the
results of pˆpen (see section 4.4.3). This parameter is replaced by the parameter δ, that it is
reasonable not to take more than 0.1 and which appears to have low impact on the result of
pˆLn (see section 4.5.3). Secondly the solution of (4.2.7) can be, it of course depends on the
choice of the dissimilarity measure L, easier to compute than the one of the optimization
problem (4.2.4) as we should see in section 4.5.
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Figure 4.2 – Barycenter between experts and data.
4.3 Related works
4.3.1 Bayesian statistics
The desire to take advantage of expert data and empirical data at the same time has of
course a very old history. This is the very essence of Bayesian statistics Gelman et al. [2004]
which consists in incorporating expert data, in the form of an a priori, into experimental
data by using Bayes’ theorem to obtain what will be called the posterior.
Our a priori concerns the marginals and a certain number of constraints on the distri-
bution to be estimated. The absence of an obvious a priori to modelize the parameter’s
distribution naturally leads us to the idea of maximum entropy theorized by Jaynes [1957].
Indeed, if no model seems more plausible to us than another, then our choice will be the
least informative. This is a generalization of the principle of indifference often attributed
to Laplace: "We look at two events as equally probable, when we see no reason that makes
one more probable than the other, because, even if there is an unequal possibility between
them, as we do not know on which side is the greatest, this uncertainty makes us look at
one as equally probable as the other" de Laplace [1774]. This principle therefore takes the
form of an axiom that allows us to construct a method for choosing an a priori: the least
informative possible compatible with what we know.
4.3.2 Expert system with probabilistic reasoning
The creation of a decision support tool for medical diagnosis has been an objective since
the beginning of the computer age. Most of the early work proposed a rules-based expert
system, but in the 1980s, a significant part of the community studied the possibility of
building an expert system using probabilistic reasoning Pearl [1989]. Bayesian probabil-
ities and methods were therefore relatively early considered as good ways to model the
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uncertainty inherent in medical diagnosis.
The assumption of conditional independence of symptoms given the disease has been
intensively discussed as it is of crucial importance for computational complexity. Some
researchers considered this hypothesis harmless Charniak [1983] while others already pro-
posed a maximum entropy approach to face this issue Hunter [1985], Shore [2013] or Miller
and Goodman [2013].
However, it seems that none of the work of that time considered the expert vs empirical
data trade-off that we face. In the review article Jirousek [1990] presenting the state-of-
the-art of the research of that time (1990) about this issue, it is clearly mentioned that
these methods only deal with data of probabilistic form. More precisely, they assume that
they have an a priori on the marginal but also on some of the combinations of symptoms (in
our case we would assume that we have a priori on P[B1, B2 | D] for example) and propose
a maximum entropy approach where these expert data are treated as constraints in the
optimization process. Once again, this is not the case for us since we have only an a priori
on the marginal (and a certain number of constraints) as well as experimental data. This
field of research was very active in the 1980s and then gradually disappeared, probably due
to the computational intractability of the algorithms proposed for the computer resources
of the time.
4.3.3 Bayesian Networks
Bayesian networks were then quickly considered as a promising alternative to model prob-
abilistic dependency relationships between symptoms and diseases Pearl [1989]. These are
now used in most expert systems, particularly in medicine Koller and Friedman [2009].
A Bayesian network is generally defined as an acyclically oriented graph. The nodes
in this graph correspond to the random variables: symptoms or diseases in our case.
The edges link two correlated random variables by integrating the information of the
conditional law of the son node given the father node. The main advantage of such a model
is that it can factorize the joint distribution using the so-called global Markov property.
The joint law can indeed be expressed as the product of the conditional distributions of
each node given its direct parents in the graph Spiegelhalter et al. [1993].
The construction of a Bayesian network implies first of all to infer its structure, i.e.
to determine the nodes that must be linked by an edge of those that can be considered
conditionally independent to the rest of the graph (structure learning). Then, learning the
network implies learning the parameters, i.e. the probabilities linking the nodes (parameter
learning).
It is therefore natural to also find in this area of the literature works that aimed at
mixing expert and empirical data. In Zhou et al. [2016] the experts’ indications take a
particular form since they indicate by hand correlations, positive or negative, between
variables. The approach of Constantinou et al. [2016] is also quite distant because it
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is preferably based on data. Constantinou et al. [2016] only uses expert indications for
additional variables for which there are no data, typically rare events never observed in the
database. A work closer to ours is Heckerman et al. [1995] where the authors assume that
they have a first Bayesian network built entirely by the experts, to which they associate
a degree of trust. The authors then use the available data to correct this expert network.
We distinguish ourselves from this work in our effort to find an objective procedure for
the weight to be given to experts in relation to the data (and for this weight not to be set
by the experts themselves).
Note also that the main interest of Bayesian networks is to take advantage of condi-
tional independence relationships known in advance, as they are pre-filled by experts or
inferred from a sufficient amount of data. However, in our case, we do not have such an a
priori knowledge about the dependency relationships between symptoms and not enough
data to infer them.
4.3.4 Bayesian Reinforcement Learning
We have presented here separately the planning part (optimal policy research) from the
transition model learning part. However, some of the literature known as Bayesian Re-
inforcement Learning proposes to combine these two objectives, see Ghavamzadeh et al.
[2016] for an overview of this area. The main aim is to reconsider in traditional rein-
forcement algorithms the notion of the exploration/exploitation dilemma. It is indeed
necessary to grant a bonus to explore further, because the transition probabilities from
not often visited states may be poorly estimated. The risk is then to miss out on good
solutions because of a poorly estimated transition model.
This exploration, in the sense of using in practice a strategy different from the optimal
policy learned, already exists in some way in our system. Indeed, the user can choose to
answer any question and not the first one we listed.
Nor have we addressed this issue and assumed that the clinical data received to estimate
the transition model are complete. This means that when the fetus is affected by a
pathology (which is far from being the most frequent case) it will be necessary to take
the time to check the presence/absence of typical symptoms, either at the time of the
ultrasound or later via additional examinations.
4.3.5 From the marginals to the joint distribution
Estimating the joint distribution from the marginal is an old problem, which is obviously
not necessarily related to expert systems. This problem is sometimes referred to in the
literature as the "cell probabilities estimation problem in contingency table with fixed
marginals". The book Bishop et al. [1975] gives a good overview of this field. We can trace
back to the work of Deming and Stephan [1940] which assumes knowing the marginal and
having access to a sample of empirical data and aims to estimate the joint distribution. In
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this article, they proposed the "iterative proportional fitting procedure" (IPFP) algorithm,
which is still very popular to solve this problem.
An important assumption of Deming and Stephan [1940] is that each cell of the con-
tingency table receives data. In Ireland and Kullback [1968] the authors prove that the
asymptotic estimator obtained by an IPFP algorithm is the distribution that minimizes
the Kullback-Leibler divergence from the empirical distribution under the constraint to
respect the marginal experts.
However, an IPFP algorithm is not suitable for our problem for two main reasons: first,
we do not have absolute confidence in the marginals given by experts (we want to allow
us to modify them as we collect more data) and second, because since we are interested
in rare diseases we do not expect to have a sufficient amount of data. In fact, many of
the cells in the contingency table we are trying to estimate will not receive data, but it
would be disastrous in our application to assign a zero probability to the corresponding
symptom combination.
In a sense, an IPFP algorithm does exactly the opposite of what we are aiming for: it
modifies empirical data (as little as possible) to adapt them to experts, while we aim to
modify experts (as little as possible) to make them consistent, in a less restrictive sense,
with empirical data.
We should also mention the work related to our problem in applications of statistics
to the social sciences where researchers aim to construct a synthetic population from
marginal coming from several inconsistent sources Barthelemy and Toint [2013]. Their
proposed approach also use ideas of maximum entropy but it is still different of our trade-
off expert vs empirical data since they build their model without samples.
4.3.6 The Kullback centroid
Our optimization problem (4.2.7) in the particular case where the dissimilarity measure
L is the Kullback Leibler divergence is called moment-projection (M-projection) in the
literature. The properties of these projections have been intensely studied Csiszár and
Matús [2003].
Note that the Lagrangian associated with such an optimization problem is then nothing
more than a Kullback-Leibler centroid. These objects or variations/generalization of them
(with Jeffrey’s, Bregman’s divergences etc...) have been the subject of research since the
paper of Veldhuis [2002]. For example, articles Nielsen and Nock [2009] and Nielsen [2013]
study cases where an exact formula can be obtained and propose algorithms when this is
not the case.
However, we have not found any use of these centroids to find a good trade-off expert
vs empirical data as we propose in this paper. Bregman’s divergence centroids have been
used to mix several potentially contradictory experts, the interested reader may refer
to the recent thesis of Adamcik [2014]. We could certainly consider that the empirical
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distribution pempn is a second expert and that our problem is the same as to mix two
experts: literature and data. However, the question of the weight to be given to each
expert, which is the question that interests us here, will not be resolved. In Adamcik
[2014] the aim is rather to synthesize contradictory opinions of different experts by fixing
in advance the weight to be given to each expert. We propose, for our part, an objective
procedure to determine the weight to be given to experts comparing to empirical data.
4.4 Proprieties and numerical experiments for the penalized
approach
4.4.1 Existence/uniqueness of a solution and numerical considerations
©
The function F defined in equation (4.2.4) we aim to optimize is C∞ on the constraint
space C which is a compact set (since C ⊂ [0, 1]2J+J), therefore F admits a maximum
in C. As F is concave (as a sum of concave functions) this maximum is unique and we
can use the Kuhn-Tucker theorem which ensures us that maximizing our function under
constraints can be achieved looking for the saddle-point of the Lagrangian.
Deriving the Lagrangian and equating it to 0, we obtain the marginals as function of
Lagrangian parameters µ. We write µ = (µ0, µ1, ..., µJ) the Lagrangian parameters where
µ0 states for the constraint
∑
j pj = 1 and each µk states for the marginal constraint
respectively to P[Bk | D]. If λj 6= 0 we have:
P[Bj | D] =
1 + 1( Pexpert[Bj | D]
1− Pexpert[Bj | D]
)
exp
(
µj
λj
)

−1
;
Note that if λj → +∞ we indeed recover P[Bj | D] = Pexpert[Bj | D].
Moreover if Nj = 0 we have:
pj = exp
(
−1− µ0

−
∑
k
µk

1{Bk=1}
)
; (4.4.1)
If Nj 6= 0 we can not obtain a closed form for pj as function of µ and we have to solve
the following equation:
− (log(pj) + 1) + µ0 +
K∑
j=1
µj1{Bj=1} +Nj
1
pj
= 0;
A dichotomy method will be suitable for this task.
Readers familiar with maximum entropy theory should not be surprised by the form
of equation (4.4.1) . We recover a classical result, see for example Berger et al. [1996], the
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solution of maxent have a nice exponential form: a Gibbs distribution.
We use an Uzawa algorithm to reach the saddle-point of the Lagrangian, see Uzawa
[1958]. Since F is a concave function we are ensured that the saddle-point we converge to
by Uzawa iteration is the global maximum of F .
4.4.2 Heuristics for parameters choice ©
There are two kind of parameters to choose:  and λj , ∀j ∈ [1,K].
We could think that  should decrease withN , but as we have chosen not to renormalize
the log-likelihood we have
L
(
x(1), ..., x(N)
)→∞
when N goes to infinity. A  parameter independent of N seems an easy calibration which
provides good results, it should just be chosen large enough to regularize the log-likelihood
when N is small (see experiences in section 4.4.3).
However  should depend on the number of unknown parameters of the distribution to
be estimated: 2J
(
J the number of typical symptoms
)
. Indeed a disease with 12 typical
symptoms (i.e. 212 possible symptoms combination) will need far more data than a disease
with 4 typical symptoms.
To calibrate  as a function of J , we should look at how the three different terms of
(4.2.4) behaves with J . Roughly speaking the entropy term H(p) is of the order of J (the
maximal values is J × log(2) reached by the uniform distribution). The Kullback-Leibler
penalization is linear in J and appears scalable to the entropy (see section 4.4.3).
As it is usually done in log-likelihood regularization we expect the log-likelihood to be
of order 2J : therefore,
 = c× 2J
where c is a non-negative constant to be determined, seems a reasonable calibration. In
practice, our decision support tool will never have a sufficient amount of data and the
maxent regularization will allow us to cope with new situations. We will take this into
account when choosing c.
Concerning λj parameters, the more confident we are in Pexpert[Bj | D] the higher is
λj . We simply have to initialize λj with sufficiently large values in order to prevent the
condition on high entropy to change the marginals too much when N is small as we will
see in section 4.4.3. Of course we should not fall into the opposite excess by taking λj too
large which would have the consequence of staying on the experts’ a priori even when the
data tell us another reality.
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Figure 4.3 – Evolution of marginals’ esti-
mates in maxent with marginals regular-
ization.
Figure 4.4 – Evolution of the divergence
between our estimate and the real symp-
tom combination distribution as function
of the amount of available data.
4.4.3 Some experiments ©
Maxent with Kullback penalization on marginals a priori
Let us start by looking at what happens when we make a maxent with Kullback regular-
ization on marginals, i.e we exclude likelihood for this synthetic experiment. Namely we
are interested in a vector Pˆ defined as follows:
Pˆ = arg max
P/P∈C
H(p)− λ
J∑
i=1
KL
(
Be
(
Pexpert[Bi | D]
)
|| Be(P[Bi | D]));
where vi ∼ Be
(
Pexpert[Bi | D]
)
and wi ∼ Be (P[Bi | D]) for all i ∈ [1, J ].
We set J = 4, with the following a priori on marginals
( 9
10 ,
8
10 ,
3
10 ,
2
10
)
=:
(
Pexpert[B1 |
D],Pexpert[B2 | D],Pexpert[B3 | D],Pexpert[B4 | D]
)
.
For this experiment, we increase λ and look at how it affects the marginals’ estimates.
We can see in figure 4.3 that all the marginals’ estimators start with value 0.63 and then
decrease or increase in a monotonous way toward their a priori. This is not surprising
since maxent tends to disseminate weight on the entire distribution making parameters of
Bernoulli marginals distribution closer to 0.5. In our case we have marginals equal to 0.63
since we enforce combinations with less than one symptom to have zero probability. This
gives us an idea of how λ should be initialized.
Adding data
We simulated a symptom combination distribution Preal (with J = 8 associated symp-
toms) using Poisson distribution of parameter 1. The estimate Pnew solution of (4.2.4)
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given by our Uzawa algorithm has been sequentially updated using data sequentially
simulated from Preal. For the a priori on marginals, we used the real marginals with
an additive Gaussian noise of zero mean and 1/4 variance. The measure of interest is
the Kullback-Leibler divergence between the real distribution and our estimate solution
of (4.2.4): KL(Pnew||Preal) which we would like to minimize. We are interested in how
the choice of  = c × 2J affects our estimation of the real distribution. To cope with
inherent randomness of this process, an average estimate of the Kullback-Leibler diver-
gence was obtained over 50 repetitions of the same procedure (i.e we simulated 50 Poisson
distributions for each different values of c).
In Figure 4.4, the red (c = 1) and black (c = 0.1) curves clearly show that giving
too much weight to the data leads to over-weighing the symptoms combinations observed
in real life and keeps us far from the real distribution: we do not sufficiently regularize
with the entropy. On the contrary the green (c = 1.8) and the orange (c = 2) curves
performs a good trade-off maxent/maximum likelihood. c = 2 is a more cautious choice
(we underweight experimental data) than c = 1.8 and as a consequence the procedure
converge less quickly to the real distribution.
Note that an empirical estimate (solution of a maximum likelihood approach) or an
IPFP algorithm would perform very poorly on this task. Indeed many symptoms com-
binations would be estimated to be 0 when they should not, because of data scarcity:
indeed we have 28 = 256 variables and less than 500 data. We have not plotted the
Kullback-Leibler divergence of these estimates with respect to the real distribution since
it is infinite. In contrast our approach appears robust to data scarcity, provided that we
take care of the value of .
4.5 Numerical experiments and theoretical properties of the
barycenter estimator
4.5.1 Barycenter in normed spaces ©
In this section we work in spaces Lp. Let us recall that the classic norm on the space Lp
is given by : ‖x‖j =
(∑
i
|xi|j
) 1
j
.
Following the ideas presented in section 4.2.3 we define our estimator, ∀i ≥ 1, ∀j ≥ 1
as follow :
pˆi,jn = arg min
p∈C/‖p−pexpert‖i≤n
‖p− pempn ‖j (4.5.1)
where
n := δn = arg min
l
P[‖pempn − p?‖i ≤ l] ≥ 1− δ. (4.5.2)
To control n we use the concentration inequality obtained in the recent work of Mardia
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et al. [2018]. In the literature, most of the concentrations inequalities for the empirical
distribution use the L1 norm. This is why, even if we will present in the following results
by trying to generalize for as many couples (i, j) as possible, in practice only the pˆ1,jn , for
all j ≥ 1, interest us.
Proposition 4.5.1 (existence and uniqueness) The estimator pˆi,jn defined by (4.5.1) exists
for all i ≥ 1, j ≥ 1.
pˆi,jn is unique if and only if i 6= 1.
In the following pˆ1,1n therefore refers to a set of probability measures.
Proof The existence of a solution of (4.5.1) for all i ≥ 1 and j ≥ 1 is a consequence of
the fact that the projection onto a finite dimension set always exists.
The uniqueness of a solution of (4.5.1) for all i 6= 1 is due to the fact that we aim to
minimize a strictly convex function under convex constraints. When j = 1 the function
that we aim to minimize is no longer strictly convex and some counter-examples can be
exhibited.
For example if pexpert = (14 ,
1
4 ,
1
4 ,
1
4), pempn = (
1
2 , 0,
1
2 , 0) et n =
9
10 .
Note that ‖pexpert − pempn ‖1 = 1 > 910 . Then using proposition 4.5.2 we know that
n
‖pempn − pexpert‖1 p
expert +
(
1− n‖pempn − pexpert‖1
)
pempn
=
(11
40 ,
9
40 ,
11
40 ,
9
40
)
=: pˆ1,1n
is solution. But p˜ = (1040 ,
9
40 ,
12
40 ,
9
40) is solution too. Indeed :
‖p˜− pexpert‖1 = 110 = ‖pˆ
1,1
n − pexpert‖1
and:
‖p˜− pempn ‖1 =
36
40 =
9
10 .
The next proposition shows that one of the solutions of (4.5.1) can always be written
as a barycenter between pempn and pexpert when i = j. This property therefore provides us,
in these cases, with an explicit expression of a solution of (4.5.1) which was not otherwise
trivial to obtain by a direct calculation looking for the saddle points of the Lagrangian
(for example in the case i = j = 1).
Proposition 4.5.2 Let pˆi,jn defined by (4.5.1) then for all i = j, it exists p˜ ∈ pˆi,jn such
that ∃αn ∈ [0, 1]:
p˜ = αnpexpert + (1− αn)pempn (4.5.3)
where αn =
n
‖pempn − pexpert‖i if n ≤ ‖p
emp
n − pexpert‖i and αn = 1 otherwise.
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Proof Let p˜ ∈ C be such that it exists α ∈ [0, 1] where p˜ = αpexpert + (1 − α)pempn and
such that ‖p˜− pempn ‖i = n. We then have :
‖p˜− pempn ‖i = α‖pempn − pexpert‖i = n
and then
α = n‖pempn − pexpert‖i .
Moreover note that we have the following equality since p˜ can be written under the
form of a barycenter :
‖p˜− pexpert‖i + ‖p˜− pempn ‖i︸ ︷︷ ︸
=n
= ‖pempn − pexpert‖i
Let us make a reasoning by reductio ad absurdum. Let us assume that there exist
p′ ∈ C such that ‖pempn − p′‖i ≤ n et ‖pexpert − p′‖i < ‖pexpert − p˜‖i.
We would then have:
‖pempn − pexpert‖i ≤ ‖p′ − pexpert‖i + ‖p′ − pempn ‖i
< ‖p˜− pexpert‖i + ‖p′ − pempn ‖i
= ‖pempn − pexpert‖i − n + ‖p′ − pempn ‖i
≤ ‖pempn − pexpert‖i
which leads to the desired contradiction.
In particular one of the elements of pˆ1,1n can be written under the form of a barycenter.
For the sake of simplicity, we will designate in the following by pˆ1,1n the solution of (4.5.1)
for i = j = 1 which can be written under the form (4.5.3) and no more the whole set of
solutions.
Remark Note that the proposition 4.5.2 is not true when i = 1 and j 6= 1. This is why
we focus on pˆ1,1n for the end of this section.
It is now a question of deriving a result proving that mixing experts and data as we
do with pˆ1,1n represents an interest rather than choosing binary one of the two models.
For this reason, we show in the following proposition that with a high probability, our
estimator pˆ1,1 is always better than the best of the models within a constant.
Theorem 4.5.3 Let pˆ1,1n defined by (4.5.1). Then we have with probability at least 1− δ:
‖p? − pˆ1,1n ‖1 ≤ 2 min{n, ‖p? − pexpert‖1} (4.5.4)
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Proof A simple application of the triangular inequality gives us :
‖p? − pˆ1,1n ‖1 ≤ ‖p? − pempn ‖1 + ‖pempn − pˆ1,1n ‖1
However ‖pempn − pˆ1,1n ‖1 ≤ n by construction and we have ‖p? − pempn ‖1 ≤ n with
probability at least 1− δ.
In addition to that :
‖p? − pˆ1,1n ‖1 ≤ ‖p? − pexpert‖1 + ‖pexpert − pˆ1,1n ‖1
However using the definition of pˆ1,1n and assuming ‖p? − pempn ‖1 ≤ n then:
‖pexpert − pˆ1,1n ‖1 ≤ ‖pexpert − p?‖1.
We can conclude that if ‖p? − pempn ‖1 ≤ n, which happens with probability at least
1− δ, then :
‖p? − pˆ1,1n ‖1 ≤ 2 min{n, ‖p? − pexpert‖1} (4.5.5)
4.5.2 Barycenter using the Kullback-Leibler divergence ©
In this section we study the theoretical properties of the solution of equation (4.2.7) in
the particular case where the dissimilarity measure L is the Kullback-Leibler divergence.
The Kullback-Leibler divergence between two discrete probability measure p and q is
defined as:
KL(p||q) =
∑
i
pi log
(
pi
qi
)
.
Let us recall that the Kullback-Leibler divergence is not a distance since it is not
symmetric and does not satisfies the triangular inequality, it is however positive defined
Cover and Thomas [2006].
We define our estimator as :
pˆLn = arg min
p∈C/KL(pempn ||p)≤n
KL(pexpert||p) (4.5.6)
where
n := δn = arg min
l
P[KL(pempn ||p?) ≤ l] ≥ 1− δ. (4.5.7)
To calibrate n, we can use the concentration inequality obtained in Mardia et al.
[2018]. More precisely we have :
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n =
1
n
− log(δ) + log
3 + 3K−2∑
i=1
√e3n
2pii
i

︸ ︷︷ ︸
=:Gn
 . (4.5.8)
In the following proposition, we show the existence and uniqueness of our estimator
pˆLn and the fact that our estimator is a barycenter. However it does not seem possible this
time, unlike the case of pˆ1,1n of the equation (4.5.1), to obtain a closed form for pˆLn .
Proposition 4.5.4 Let pˆLn defined by (4.5.6) then pˆLn exists and is unique. Moreover pˆLn
can be written under the following form :
pˆLn =
1
1 + λ˜
pexpert + λ˜
1 + λ˜
pempn (4.5.9)
where λ˜ is a non-negative real such that:
λ˜ ≥ KL(p
emp
n ||pexpert)
n
− 1. (4.5.10)
Proof The existence and uniqueness of pˆLn is a consequence of the fact that T = {p/p ∈
C and KL(pempn ||p) ≤ n} is a convex set. Indeed let p, q ∈ T , α ∈ [0, 1] then using the
classical log-sum inequality we have:
KL(pempn ||αp+ (1− α)q) ≤ αKL(pempn ||p) + (1− α)KL(pempn ||q) ≤ n.
The Lagrangian associated to the optimization problem (4.5.6) can be written as :
L(p, λ, µ) =
∑
i
pexperti log
(
pexperti
pi
)
+ λ
(∑
i
pempi log
(
pempi
pi
)
− n
)
+ µ
(∑
i
pi − 1
)
Deriving for all i ∈ [1,K]:
∂L(p, λ, µ)
∂pi
= −p
expert
i
pi
− λp
emp
i
pi
+ µ
Equating this last expression to 0 and using the fact that the probability measures
sums to 1 we find : µ = λ+ 1. Then we have for all i ∈ [1,K]:
pi =
1
1 + λp
expert
i +
λ
1 + λp
emp
i
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We know that pˆLn exists and is unique and using the Kuhn-Tucker theorem (whose
assumptions we satisfy since we minimize a convex function under convex inequality con-
straints) we know that the minimum of the optimization problem (4.5.6) is reached for
the saddle-point of the Lagrangian : (λ˜, p˜) = (λ˜, pˆLn). We can then write :
pˆLn =
1
1 + λ˜
pexpert + λ˜
1 + λ˜
pempn (4.5.11)
We could not obtain a closed form for λ˜ unlike the case of pˆi,i. however we know that
by construction KL(pempn ||pˆn) ≤ n.
Moreover using the log-sum inequality and our interpolation formula (4.5.11) we have:
KL(pempn ||pˆn) = KL
(
pempn ||
1
1 + λ˜
pexpert + λ˜
1 + λ˜
pempn
)
≤ 1
1 + λ˜
KL(pempn ||pexpert).
We then have the following condition under λ˜ :
1
1 + λ˜
KL(pempn ||pexpert) ≤ n ⇔ λ˜ ≥
KL(pempn ||pexpert)
n
− 1
The following proposition is intended to be the analog of the proposition 4.5.3 when
L is the Kullback-Leibler divergence. We prove that the centroid pˆLn is better than the
experts (with high probability). On the other hand, we obtain that when KL(pempn |||p?) >
KL(pexpert||p?), the pˆLn barycenter is better than the empirical distribution. To obtain
guarantees when KL(pempn ||p?) ≤ KL(pexpert||p?) seems less obvious and requires control
over the quantity KL(pempn ||pexpert).
Theorem 4.5.5 Let pˆLn defined by (4.5.6) then we have with probability at least 1− δ:
KL(pˆLn ||p?) ≤ min
{
KL(pexpert||p?), n (Ln + 1)
}
(4.5.12)
where
Ln =
KL(pexpert||p?)−KL(pempn ||p?)
KL(pempn ||pexpert) .
Proof Using the proposition 4.5.4 we have :
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KL(pˆLn ||p?) = KL
(
1
1 + λ˜
pexpert + λ˜
1 + λ˜
pempn ||p?
)
≤ 1
1 + λ˜
KL(pexpert||p?) + λ˜
1 + λ˜
KL(pempn ||p?)
= 1
1 + λ˜
(
KL(pexpert||p?)−KL(pempn ||p?)
)
+KL(pempn ||p?)
≤ n
(
KL(pexpert||p?)−KL(pempn ||p?)
KL(pempn ||pexpert)
)
+KL(pempn ||p?)
where we used the available inequality to λ˜ (the proposition 4.5.4) in the last inequality
and the desired result is obtained by assuming that KL(pempn ||p?) ≤ n which happens with
probability at least 1− δ.
In addition, note that :
n
(
KL(pexpert||p?)−KL(pempn ||p?)
KL(pempn ||pexpert)
)
+KL(pempn ||p?)
≤ KL(pexpert||p?)
⇔ n ≤ KL(pempn ||pexpert)
However, if n ≥ KL(pempn ||pexpert) we have by construction that pˆLn = pexpert and
therefore KL(pˆLn ||p?) = KL(pexpert||p?).
We can conclude from all this that :
KL(pˆLn ||p?) ≤ KL(pexpert||p?).
Remark Note that KL(pˆLn ||p?) is infinite if pexpert does not have the same support that
p?. Nevertheless obtaining a result for KL(p?||pˆLn) would require to have a concentration
on KL(p?||pˆempn ) which we do not have. Note that KL(p?||pˆempn ) is infinite until we have
sampled at least one time all the elements of the support of p?.
4.5.3 Some numerical results ©
For each experiment in this section, we generate a random distribution p? that we try
to estimate. To do this, we simulate some realizations of a uniform distribution and
renormalize in order to sum up to 1.
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We also generate four different distributions that will serve as a priori for the infer-
ence: pexpert,i, ∀i ∈ {1, 2, 3, 4}. The first three priors are obtained by a maximum entropy
procedure under constraint to respect marginals of p? having undergone a modification.
We added to the marginals of p? a Gaussian noise of zero expectation and variance equal
to σ21 = 0.1, σ22 = 0.2 and σ23 = 0.4 respectively. The last priority pexpert,4 is chosen equal
to the distribution p? (the experts provided us with the right distribution).
We then sequentially sample data from p?, i.e we generate patients, and update for
each new data and each different a priori, the left centroid pˆLn (using an Uzawa algorithm),
the barycenter pˆ1,1n , the empirical distribution pempn as well as the divergences KL(pˆLn ||p?)
and KL(pempn ||p?) and the norms ‖pˆ1,1n − p?‖1 and ‖pempn − p?‖1.
The experiments of figures 4.5, 4.6, 4.8 were conducted on a case of a disease with J = 7
typical symptoms and where there is therefore K = 27 = 128 possible combinations. The
experiments of figures 4.7 and 4.9 were conducted on a case of a disease with 9 typical
symptoms and where there is therefore K = 29 = 512 possible combinations.
The only parameter we can control is the δ used to construct the confidence interval of
the concentration of the empirical distribution around the true distribution. Let us recall,
that for the case of the Kullback centroid of the equation (4.5.6) we set :
n =
1
n
(− log(δ) + log(Gn)) (4.5.13)
where Gn is defined in equation (4.5.8).
However, our first numerical experiments show that the choice of n defined by the
equation (4.5.13) is a little too conservative: see figure 4.5. We need to converge n faster
towards 0 without abandoning our a priori when it is good.
Our experiments suggest taking a n consistent with the proposed concentration in a
conjecture of Mardia et al. [2018] for Kullback-Leibler divergence :
n =
− log(δ) + n2 log
(
1 + K−1n
)
n
. (4.5.14)
Note that we added a constant 12 to the conjecture of Mardia et al. [2018]. As for
the choice of δ, this appears important mainly when n is small, taking it sufficiently low
avoids an overfitting situation when the number of data is still low without being harmful
when n is high. We took it equal to 10−6 in all our experiments.
The figure 4.9 shows that our approach is not very sensitive to the choice of δ which
is an advantage compared to the penalized approach.
The figures 4.8 and 4.7 show that such a choice for n makes a good trade-off between
expert and empirical data because we are able to take advantage of these two sources of
information when the number of data is small (typically when n < K), but also to quickly
abandon our a priori when it is bad (see the black curves) or to keep it when it is good
(the green curves). Eventually the figures 4.8, and 4.7 were performed on problems of 128
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Figure 4.5 – Evolution of the performance of pˆLn as a function of the available number of
empirical data. n defined by equation (4.5.13)
and 512 respectively and this choice of n therefore appears relatively robust to changes
in size.
Concerning pˆ1.1n , we took, still following the conjectures of Mardia et al. [2018]:
n =
√√√√− log(δ) + n2 log (1 + K−1n )
n
. (4.5.15)
The figure 4.6 shows the error made by our barycenter in norm L1: pˆ1,1n using such a
n. We are again able to get rid of a bad a priori relatively quickly to follow the empirical
(green curve) while keeping it if it is good (blue curve).
Moreover we show with these experiments that there is an intermediate regime, when
we do not have much data, where our estimator is strictly better than the two models
(experts and data alone). This is particularly visible when we used the n of the conjecture
of Mardia et al. [2018], see figure 4.7 and 4.8. It is then an empirical evidence that mixing
these two heterogeneous sources of information, experts and empirical data, can be useful
for statistical inference.
Note that there is some limitations to these experiments. The way we simulate the
distributions we are trying to estimate (the p?) produces quite specific distributions: close
to the uniform and dense. If we simulate more sparse distributions, our a priori pexpert
built from the entropy maximum heuristic will be bad and the experiments will no longer
be as interesting.
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Figure 4.6 – Evolution of the performance of pˆ1,1n as a function of the available number of
empirical data. n defined by equation (4.5.15).
Figure 4.7 – Evolution of the performance of pˆLn as a function of the available number of
empirical data. n defined by (4.5.14). Number of symptom : 9.
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Figure 4.8 – Evolution of the performance of pˆLn as a function of the available number of
empirical data. n defined by (4.5.14). Number of symptom : 7.
Figure 4.9 – Evolution of the performance of pˆLn as a function of the available number of
empirical data with different initial a priori and δ. n is defined by equation (4.5.13)
Number of symptom : 7.
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4.6 High-dimensional issues
4.6.1 Explosion of the dimension of symptoms distributions
We are able to estimate the symptom combination distribution
(P of formula (4.2.3)) of
each disease D provided that we can store this vector (i.e K is small enough). Note that
we actually need a larger vector, as our algorithm processes the information collected by
the physician sequentially. For example, we will need the P[B1, B2 | D] probability, which
is not in P if K 6= 2.
There are two possible solution for a disease with K typical symptoms:
• To store the bigger vector of dimension 3K since we would need to code in ternary
to include the information "not seen yet" relative to a given symptom or
• To store the smaller vector of dimension 2K and compute, on the fly, to recover
desired symptoms combination probabilities from available ones.
As we will intensively use our environment model for training our decision support system,
we should prefer the first solution, as much as possible.
However, it clearly appears that we will not be able to compute/store the distribution
of symptoms combination for all the diseases. Indeed when a diseases has a large number
of K typical symptoms, the dimension of the vector Pnew we aim to estimate explode:
3K .
To cope with this issue, we will use the available ontological information about symp-
toms, i.e the fact that a symptom can be described at different level of precision and make
less stringent assumption about the dependence between symptoms (see section 5.3).
4.6.2 Relaxing the model to face potential database default
So far, our model relies heavily on the assumption that expert data gives an exhaustive
representation of each diseases. If a symptom has been forgotten for a disease in our
expert data list, we would not be able to recover the disease.
That is the reason why we make the assumption that a non-typical symptom (i.e. a
symptom that have not been associated to the disease in the expert data) may be observed
in a patient with disease D, but with a small (10−5) probability and independently of other
symptoms.
4.7 Conclusion
In this chapter we have presented a way to combine expert knowledge, taking the form of
marginal probabilities and rules, to real clinical data so as to estimate the joint distribution
of the symptoms combinations given the disease.
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The particular form of the prior does not allow us to simply adopt a maximum a pos-
teriori (MAP) approach. The absence of a classical prior modeling the model parameters
with a particular probability distribution lead us naturally to a maxent approach : if no
model seems more plausible to us than another, then we will choose the least informative.
This idea of maximum entropy brings us back to the works of the 80s’ and 90 s’ where
researchers also aimed to build a symptom checker using the marginals. In our work we
go further by gradually integrating clinical data as the algorithm is used.
We are interested in the intermediate regime where we do not have enough clinical
data to do without experts but have enough to correct them if necessary. Our proposal is
to construct our estimator as the distribution closest to the experts’ initial a priori, in the
sense of a given dissimilarity measure, that is consistent with the empirical data collected.
We prove, both theoretically and empirically, that our barycenter estimator mixing the
two sources of information is always more efficient than the best of the two models (clinical
data or experts alone) within a constant.
We have empirically illustrated the effectiveness of the proposed approach by giving a
priori of different quality and incrementally adding clinical data. We have shown that our
estimator allows a bad a priori to be abandoned relatively quickly when the inconsistency
of the data collected with the initial a priori is observed. At the same time, this same
mixture makes it possible to keep the initial a priori if it is good.
Moreover we show with this experiment that, in the intermediate regime, our estimator
can be strictly better than the best of the two models (experts and data alone). It
empirically confirms the idea that mixing these two heterogeneous sources of information
can be profitable in statistical inference.
Several refinements are possible such as the addition of a kernel structure for the
construction of the empirical distribution. Indeed it is possible that there are omissions of
some symptoms in the data collected. Then a kernel approach that would consider states
that only differ by some presences as closer would capture such a difficulty and makes a
better use of empirical data.
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Chapter 5
Probabilistic reasoning on
ontologies
Abstract: In this chapter we give more details concerning the inte-
gration of ontological information in our decision support tool for the
diagnosis of rare diseases. This is a crucial aspect as we aim to give
more freedom to the user allowing him to provide information about the
symptoms at different level of granularity. We present a way to inte-
grate this information while remaining in our probabilistic setting and
without computational explosion. Finally we make the link between the
tree structure of the symptoms and the way to modelize and store the
distribution of the symptoms given the disease.
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Figure 5.1 – A (very) short extract of the cardiac system ontology.
5.1 Introduction
So far we described the diseases as combinations of symptoms. We designed algorithms
inquiring about symptoms so as to find the right disease while minimizing the average
number of questions to ask. We have seen that in order to learn a good strategy, we need
to learn a model of the environment, i.e to learn the symptom combination distributions
given the disease.
Nevertheless a decision support system built in this way will suffer from several issues.
Indeed, the symptoms in medicine can be described at several level of granularity. A con-
crete example is given in Figure 5.1 for the abnormality "hypoplasia of the right ventricle"
(the terms range from the least precise to the most precise).
In medicine, these kind of trees, called ontology, are commonly used to represent
the knowledge on symptoms hierarchy. These ontologies are built in order to capture
the structure and relations between symptoms. Medical ontologies can bear an (almost)
infinite level of granularity.
A naive decision support system, i.e which would not include the available ontological
information, could ask irrelevant question to a physician. For example, it is perfectly
possible that our decision support would advice looking for an hypoplasia of the right
ventricle when the physician already mentioned that there is no morphological abnormality
of the heart. It is this kind of non-sense that we aim to solve in this chapter.
Furthermore our decision support tool appears, at the moment, too rigid. Indeed, we
could ask for an "hypoplasia of the right ventricle" when the physician could not give us
such a precise information but rather a more imprecise one like "there is an abnormality
of the cardiac ventricle". We should be able to deal with such imprecise answers and then
give to the physician more freedom when interacting with our decision support tool while
avoiding an explosion in computing time. Once again the use of the ontology allows us
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such an improvement.
By doing so we will be able to adapt to less experienced users which are not always
able to precise exactly the nature of the abnormality but who can say that something is
not going well on a particular region of the patient’s body. This is a good way to handle
the uncertainty we can have in the users answer. We therefore remain in the setting where
the answer are binary ("yes" or "no") but allow the user to provide answers at different
level of precision.
5.2 A less rigid decision support tool without computation
explosion
Each symptom of our initial database has been mapped to the HPO database. We, then,
have been able to extract the underlying tree structure linking the different HPO codes.
To be more precise, we know for each HPO code (a given description of a symptom), all
its descendants (more precise description of such symptom) as such as all its ascendants
(less precise description of such symptom).
5.2.1 The idea ©
As previously explained, we aim at giving more freedom to the users when describing the
symptoms they observed, giving them the possibility to describe the symptoms at different
level of granularity.
Then, instead of giving answers at a given level of granularity (our initial list of symp-
tom), one could allow the physician to choose any of the HPO code. It involves an
explosion in the number of possible symptoms: our former list of symptoms references
some 200 signs when the HPO ontology has around 1300. Both our way to modelize the
symptoms combination distributions and our learning algorithms will not be able to cope
with such an explosion.
Theoretically each patient could be unique if its symptoms are described to a sufficient
level of accuracy. Nevertheless, when we list the typical symptoms of a disease, we try to
generalize and find patterns in patient profiles. The idea is too still modelize the symptoms
combination distributions with our initial database (the one with 200 symptoms) preserv-
ing the ability of generalization our algorithms. We still propose symptoms to check at the
level of granularity of the initial database but allow the user to give answers at a different
level of granularity (any HPO code can be chosen). By proceeding in this way we obtain a
less rigid decision support without computation explosion since all computation are done
at the initial level of granularity.
For such an objective, we need a function translating the received imprecise information
(the HPO code) into usable information (presence/absence of symptoms at our granularity
level). Such a function involves deterministic and stochastic rules.
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5.2.2 Deterministic rules
Our function associating to each HPO code the usable information implies some automatic
(deterministic) rules. Namely:
• If we received a positive answer for a given HPO code, all its ascendants should be
given a positive answer too.
• If we received a negative answer for a given HPO code, all its descendants should be
given a negative answer too.
In practice, we store during the medical examination all the information given about the
HPO codes selected by the user. In order to compute the probability of each disease, we
need to check, for each HPO code and each disease, if this HPO code is in the list of the
symptoms related to this disease. If not we have to check whereas ascendants or descen-
dants of this HPO code are in this given list of symptom. Following our two deterministic
rules, if the HPO code was declared to be present we have to check if ascendants are in
the list, if it was declared to be absent we have to check the descendants.
If the HPO code verifies all the following assertions it can be considered as non typical
and treated in consequence (namely its presence is unlikely as in section 4.6.2):
• The HPO code is not in the list of symptoms related to the disease.
• It is present (respectively absent) and its ascendants/descendants (respectively de-
scendants) are not in the list.
Note that the second point involves a relation that we have not studied until then.
Indeed, what happens if we observed the presence of an abnormality which HPO code is
not in the list of symptoms of the disease but has descendants which are in the list? This
issue is studied in the next section.
In practice all these operations can be pre-computed in order to minimize the online
computation time required. It is here a matter of adapting the algorithm of section 7 which
takes as input a list of presence/absence of symptoms and output the probabilities of all
the diseases. An easy way to do it is to store in a list indexed on symptoms, the position
the symptom has (or one of its ascendant/descendant has) in the list of typical symptoms
of each disease. We should also encode if it was the symptom term, one ascendant or
a descendant which was in the list of typical symptoms as it will not involve the same
deterministic rule.
5.2.3 Stochastic rules ©
Let us assume that we have observed the presence of an "abnormal heart morphology" but
that the disease we are interested in only has in its list of typical symptom the "Hypoplasia
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of the right ventricle". How to take into account such an imprecise information? We need
decision stochastic rules for this issue.
When receiving the information of the presence of a HPO code, we have to determine
which of its descendants are in the list of symptoms of our first database (the one which
we use to build our environment model). All these symptoms have a known probability
of apparition (given what we already observed) and we are able to compute them.
Indeed let us denote L a list of symptom for which there is no descendant in our
initial database or which are absent. Then let assume that we observed the presence of a
symptom which potential descendants are B(1)1 , B
(1)
2 , B
(1)
3 and B
(1)
4 and the presence of a
second symptom which potential descendants are B(2)1 and B
(2)
2 .
There are then 4 × 2 = 8 possible combinations. Indeed, without any additional
assumption the number of possible combinations could be large. This is why we assume
that for each imprecise answer there is only one descendant which is present at a time.
Our function first computes ∀i, j,D:
P [B(1)i , B
(2)
j , L | D].
It is just the matter of searching for each D which are the typical symptoms in the list
B
(1)
i , B
(2)
j , L and use the deterministic rules if necessary.
We can then compute
P [B(1)i , B
(2)
j | L] ∝ P [B(1)i , B(2)j , L] =
∑
D
P [B(1)i , B
(2)
j , L | D]P [D].
We display the probability of each disease by (we denote B˜ for the fuzzy state associated
to the 8 possible states B(1)i and B
(2)
j ):
P [D | B˜, L] = P [D | L,∪i,j(B(1)i ∩B(2)j )]
∝ P [L,∪i,j(B(1)i ∩B(2)j ) | D]P [D]
=
∑
i,j
P [L,B(1)i , B
(2)
j | D]P [D].
5.2.4 Optimize the strategy on the leaves of the ontological tree and
then go back up ©
Our stochastic rule can be expensive in terms of computing resources while it is of crucial
importance for us to be able to interact quickly with our environment when training our
agent. Therefore, the idea is to optimize the subtasks which start from symptoms which
does not have any descendants in our database (the leaves). By this way we do not have
to use our stochastic rule while training the neural networks.
It is moreover easy to derive the strategy we have to follow when we receive an imprecise
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answer during an exam. We denote s˜ the fuzzy state and (s(i))i=1,...,d˜ the associated
possible states. We can compute the Q-values in this fuzzy state by averaging on the
Q-values on the possible states:
Qpi(s˜, a) =
d˜∑
i=1
p(s(i) | s˜)×Qpi(s(i), a). (5.2.1)
In practice, when receiving an imprecise answer, our algorithm should ask all the time
to the physician if he could provide a more precise answer. If not, a computation as (5.2.1)
has to be performed in real time during the examination. This computation should not
last more than a second, otherwise we can consider that the provided information was not
precise enough and can be overlooked.
To avoid using the stochastic rules while training our agent we need also to remove
all the action which has descendants and replace them by their leaves. In a future work
it would be interesting to allow different levels of granularity for the action that would
suggest the neural network.
5.3 Relations between the ontology and the symptom com-
bination representation ©
We insisted in section 4.6.1 that there are some cases where we are not able to compute
Pnew but we still want to be able to compute quickly the probabilities P [S1, ..., Sj | D]
without making the assumption of conditional independence. The only solution is to
relax our model of dependence between symptoms. We assumed so far that there was
dependence between all the symptoms of a disease, we should now consider dependence
with a less stringent approach. For the clarity of our presentation, we consider here a
two-stage deep ontology with a deeper stage for specific symptoms description and a more
vague level for organs.
Let us assume we are interested in a disease with K1 cardiac typical symptoms
(C1,...,CK1) and K2 renal typical symptoms (R1,...,RK2). We denote:
R =
1 if there is at least one renal abnormalities0 otherwise .
Then we assume (precise) symptoms from distinct organs are conditionally independent
given which organs have abnormalities, so we have the following decomposition:
P [C1, ..., CK1 , R1, ..., RK2 | D] = P [C1, ..., CK1 | C,D]
× P [R1, ..., RK2 | R,D]
× P [C,R | D].
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Note that even if we have lost the possibility to store dependence between precise symp-
toms from different organs (Ci and Rj), we keep a model of dependence at the higher level
in ontology: dependence between organs abnormalities (C and R).
Instead of computing and storing all symptoms combinations, we just store the symp-
toms combinations inside organs and organs combinations.
The probability of symptom combinations (i.e P [C1, ..., CK1 | C,D] in our example)
are computed using the ideas of chapter 4 with the assumption to present at least one
symptom (which was yet an assumption before). The organs abnormality combinations
P [R,C | D] are computed too using the ideas of chapter 4. When marginals P [R | D]
or P [C | D] are not known we can treat them as missing values or try to approximate
them using marginals of the lower level, temporarily making some kind of conditional
independence assumption.
Each symptom combination can be easily computed using the law of total probability,
for example we have the following decomposition:
P [R¯1, C1 | D] =P [R¯1 | R¯,D]× P [C1 | C,D]× P [R¯, C | D]
+P [R¯1 | R,D]× P [C1 | C,D]× P [R,C | D]
where P [R¯1 | R¯,D] = 1 and all the other probabilities have been stored making these kind
of computations very cheap.
This approach is in fact perfectly adapted for several diseases which manifested them-
selves in combinations of symptoms coming from specific organs. For example VACTERL
syndrome is a rare genetic diseases defined by a combination of at least three abnormalities
from three distinct organs Solomon [2011] among vertebral anomalies, anorectal malforma-
tion, cardiovascular anomalies, tracheoesophageal fistula, esophageal atresia, renal and/or
radial anomalies and limb defects (thus defining the acronym of the disease by their first
letter).
Then we are able to cope with any symptom combination distribution even when the
number of related symptoms to a disease is high. In such a case we have to find ascendants
common to several of these symptoms (which is always possible by definition) that will
organize the symptoms in groups (the organs in our example of VACTERL). We then
make the conditional independence assumption between symptoms given the ascendants.
Figure 5.2 displays the distribution of symptom combinations of VACTERL syndrom
obtained with this group modeling. We plotted the 219 ≈ 500000 points with some in
transparency for visibility reasons. Symptom combinations modeled as impossible because
there are not sufficient groups turned on, are plotted in red. Comparing this plot to the one
obtained making the conditional independence assumption (see Figure 5.3), it appears that
group modeling adds much information about the distribution of symptom combinations.
The visible symmetries of the distribution are only due to the lexicographic order we use
for the different symptom combinations.
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Figure 5.2 – Symptoms combinations dis-
tribution for the VACTERL syndrome ob-
tained by maxent with group modeling.
Figure 5.3 – Symptoms combinations dis-
tribution for the VACTERL syndrome ob-
tained by making the conditional indepen-
dence assumption.
5.4 Related works
The objective of integrating the symptom ontology when building a decision support tool
for medical diagnosis purpose is an area of research in itself.
The recent thesis of Donfack Guefack [2013] provide a good overview of this research
field which is mainly frequented by biostatisticians and computer scientists. Ontologies
has been first used for rules-based decision support tool using the Web Ontology Language
(OWL), see Valérie Bertaud-Gounot [2012]. OWL is a widely used ontological knowledge
model but it does not handle probabilistic reasoning. Thus an effort of the community
has been to developed an extension that would handle probabilistic ontologies : Pr-OWL
see Costa and Laskey [2006].
A classic way to handle ontology is to use the information content (IC) Köhler et al.
[2009], Resnik [1995]. The IC of a symptom is defined as the negative natural logarithm
of the frequency of this symptom term (and its descendants term) in the database. For
example if Bi is a given symptom, following the principle of information theory Cover and
Thomas [2006] its information content is given as follow :
IC(Bi) = − log
(
fi
|D|
)
where fi is the number of time the symptom Bi (or one of its descendant) appears in
the list of typical symptom of the diseases.
Then a symptom term is all the more informative because it is rare. The symptom
term at the root of the ontology (such as "phenotypical abnormality" for example) are
indeed much less informative than "hypoplasia of the right ventricle".
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In Köhler et al. [2009] the similarity between a set of signs Q = (B1, ..., B|Q|) and a
disease D whose associated symptoms belong to the set B(D), is defined as the sum of the
IC of their most informative common ancestor (MICA):
sim(Q→ D) = 1|Q|
 ∑
Bi∈Q
max
Bj∈B(D)
IC(MICA(Bi, Bj))

This similarity score is symmetrized by setting:
sim(P,D) = 12sim(Q→ D) +
1
2sim(D → Q).
As we do not know a priori which values of this score of similarity between a set
of symptom P and a disease D represents a good match, Köhler et al. [2009] propose to
generate random sets of symptom P and to compute the average score of similarity (Monte-
Carlo estimation with 100000 simulations). If a score obtained for a given set of symptom
P and a given disease D is statistically significantly higher than the score computed for
random set it means that it is plausible that the set of symptom P is symptomatic of the
presence of disease D.
Note that the score sim(P,Q) depends on the number |P | of symptoms in the set P ,
then the Monte-Carlo estimation has to be done for every possible value of |P |.
Although such an approach is interesting, it does not fit our requirement to remain
within a probabilistic framework.
5.5 Conclusion
In this chapter we have presented a way to efficiently deal with the fact that the information
about the symptoms can be provided at different level of granularity. The integration of
such a feature to our decision support tool is essential as it allows us to be less rigid in
our interactions with the users. We can then take into account the user uncertainty while
remaining in the binary framework of the abnormalities. We proved that it is possible
to integrate this ontological reasoning while remaining in the probabilistic framework
presented in the previous chapters.
Finally we connected these reflections to the problem of representing the distribution
of the symptoms given the disease. The ontology provide us a natural way to group
anomalies together or to simplify their interdependent relationship when there are too
many symptoms typical of a disease to assume that they are all connected.
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Chapter 6
CONCLUSION
6.1 Summary
The aim of this thesis was to construct a decision support system for the diagnosis of rare
disease in obstetrics.
In a first step, we have tried to define what a good decision support system for the
diagnosis of rare diseases should be when the cost of the medical tests is negligible against
the potential cost of a misdiagnosis. This led us to an original formulation of the optimiza-
tion problem related to the task of training a symptom checker. We tried to minimize the
average number of medical tests to be performed before reaching a pre-determined high
level of certainty about the disease of the patient. We proposed to measure this level of
certainty using entropy because its properties ensure us that on average the uncertainty
about the patient’s disease would not have increased if we had inquired more symptoms.
We investigated several reinforcement learning algorithms and made them operational
in our very high dimensional environment. To do this, we have divided the initial task
into several subtasks and learned a strategy for each subtask. We have empirically proven
that an appropriate use of intersections between subtasks can significantly accelerate the
learning process. We have also proven that a traditional greedy strategy (CART) can be
largely outperformed by strategies learned with reinforcement learning algorithms.
In addition, we have investigated the task of building a model of the environment that
we can use as a simulator to train good diagnostic strategies.
To do so we have reconnected with the first works on expert systems using probabilistic
reasoning by proposing a maximum entropy approach. This is because of our intended
application, we are interested in rare diseases and we cannot work without the knowledge
of experts (or the literature) that is generally expressed as conditional probabilities.
In this thesis, we go further by investigating the possibility to progressively improve
the initial a priori given by the experts by integrating the clinical data collected as the
algorithm is used. We have investigated several approaches and finally proposed to define
the estimator mixing expert and empirical data as the distribution the closest to the initial
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expert a priori, in the sense of a certain dissimilarity measure, which is consistent with
the collected data. We have proven, both theoretically and empirically, that an estimator
defined in this way is always more efficient than the best of the two models (expert or
data alone) within a constant. For the intermediate regime that particularly interest us,
i.e when we do not have enough data to do without experts but yet enough to correct
them if necessary, we empirically observed that our estimator is strictly better than the
best of the two models expert or data alone.
In the last chapter we have presented some solutions to integrate the available infor-
mation on the symptom tree structure to our decision support tool. Most of the work on
that question has been done by the biostatistician community. Here we have proven that
it is possible to integrate ontological considerations while remaining in our probabilistic
setting and without computational explosion.
Finally, this decision support system has been tested internally at Necker Hospital on
a fetopathology dataset, which is independent of the dataset that we used to train our
algorithms. We get very good results; indeed more than 90% of the scenarios led to a
good diagnosis. Most of the errors are due to defects in our dataset, as synonym issues or
omissions, that are currently under correction. A larger-scale study is in progress.
6.2 Future research prospects
See annex 2 (confidential).
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Titre : Méthodologie d’aide à la décision pour le dépistage anténatal échographique d’anomalies
fœtales par apprentissage statistique
Mots clés : optimisation de prise de décision séquentielle, optimisation d’arbre de décision,
aide au diagnostic médical, planification dans des espaces de très grande dimension, mélange
experts/données, raisonnement probabiliste dans des ontologies
Résumé : Dans cette thèse, nous proposons
une méthode pour construire un outil d’aide à
la décision pour le diagnostic de maladie rare.
Nous cherchons à minimiser le nombre de tests
médicaux nécessaires pour atteindre un état
où l’incertitude concernant la maladie du pa-
tient est inférieure à un seuil prédéterminé. Ce
faisant, nous tenons compte de la nécessité dans
de nombreuses applications médicales, d’éviter
autant que possible, tout diagnostic erroné.
Pour résoudre cette tâche d’optimisation, nous
étudions plusieurs algorithmes d’apprentissage
par renforcement et les rendons opérationnels
pour notre problème de très grande dimension.
Pour cela nous décomposons le problème ini-
tial sous la forme de plusieurs sous-problèmes
et montrons qu’il est possible de tirer par-
tie des intersections entre ces sous-tâches pour
accélérer l’apprentissage. Les stratégies ap-
prises se révèlent bien plus performantes que
des stratégies gloutonnes classiques. Nous
présentons également une façon de combiner les
connaissances d’experts, exprimées sous forme
de probabilités conditionnelles, avec des don-
nées cliniques. Il s’agit d’un aspect crucial
car la rareté des données pour les maladies
rares empêche toute approche basée unique-
ment sur des données cliniques. Nous mon-
trons, tant théoriquement qu’empiriquement,
que l’estimateur que nous proposons est tou-
jours plus performant que le meilleur des deux
modèles (expert ou données) à une constante
près. Enfin nous montrons qu’il est possible
d’intégrer efficacement des raisonnements ten-
ant compte du niveau de granularité des symp-
tômes renseignés tout en restant dans le cadre
probabiliste développé tout au long de ce tra-
vail.
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Abstract: In this thesis, we propose a method
to build a decision support tool for the diagnosis
of rare diseases. We aim to minimize the num-
ber of medical tests necessary to achieve a state
where the uncertainty regarding the patient’s
disease is less than a predetermined threshold.
In doing so, we take into account the need in
many medical applications, to avoid as much as
possible, any misdiagnosis. To solve this opti-
mization task, we investigate several reinforce-
ment learning algorithm and make them oper-
able in our high-dimensional. To do this, we
break down the initial problem into several sub-
problems and show that it is possible to take
advantage of the intersections between these
sub-tasks to accelerate the learning phase. The
strategies learned are much more effective than
classic greedy strategies. We also present a way
to combine expert knowledge, expressed as con-
ditional probabilities, with clinical data. This is
crucial because the scarcity of data in the field
of rare diseases prevents any approach based
solely on clinical data. We show, both empiri-
cally and theoretically, that our proposed esti-
mator is always more efficient than the best of
the two models (expert or data) within a con-
stant. Finally, we show that it is possible to
effectively integrate reasoning taking into ac-
count the level of granularity of the symptoms
reported while remaining within the probabilis-
tic framework developed throughout this work.
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